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Abstract
The blood-brain barrier (BBB) represents an important component of the central nervous system. It 
shields the CNS parenchyma from uncontrolled entry of blood-borne molecules and cells. There is a 
time period in the early postnatal development, the "window of susceptibility", during which the 
permeability of the BBB is increased. This leads to a higher risk of young animals and babies to 
experience persisting brain damage in response to inflammatory stimuli. This phenomenon possibly 
occurs because of altered blood-brain barrier properties (“leaky” brain blood vessels) and different 
chemokine expression patterns in the immature brain.
We will briefly characterize postnatal brain and spinal cord development and subsequently focus on 
the comparison of global chemokine expression patterns in different parts of the rats’ central 
nervous system (cerebral cortex, cerebellum, medulla oblongata, and spinal cord). Via pathway-
focused microarrays we will examine the changes in the expression of chemokine transcripts over
time, from postnatal day 0 to postnatal day 28. Additionally, we compare differences in chemokine 
expression patterns between wild-type Lewis rats that have an intact CNS, and transgenic Lewis rats
that overexpress myelin proteolipid protein and that are characterized by myelin degeneration and 
myelin repair processes. Finally, we examine the effects of one of the differentially expressed 
chemokines on blood-brain barrier endothelial cells in vitro.
This diploma thesis will shed more light on the conditions influencing the “window of susceptibility” 
and on mechanisms that could alter blood-brain barrier properties leading to an increased 
permeability.
Kurzfassung
Die Blut-Hirn Schranke stellt einen wichtigen Bestandteil des Zentralnervensystems dar. Sie dient 
dazu, den unkontrollierten Eintritt von im Blut enthaltenen Stoffen und Zellen in das Gehirn zu 
verhindern. In der frühen postnatalen Entwicklung scheint es ein Zeitfenster zu geben, in welchem 
eine erhöhte Anfälligkeit für bleibende Hirnschäden in Folge von Entzündungen besteht. Dies scheint 
vor allem auf eine erhöhte Permeabilität der Blut-Hirn Schranke in diesem Zeitraum zurückzuführen 
zu sein. Zusätzlich vermutet man, dass das Expressionsmuster von Chemokinen im unreifen Gehirn 
stark von jenem im adulten abweicht.
Im Laufe dieser Diplomarbeit untersuchen wir die postnatale Entwicklung verschiedener 
Gehirnbereiche sowie des Rückenmarks und widmen uns dann dem globalen Expressionsmuster von 
Chemokinen in verschiedenen Bereichen des Zentralnervensystems (Großhirnrinde, Kleinhirn, 
Hirnstamm und Rückenmark) von Ratten. Mit Hilfe von fokussierten Micro-Arrays, welche nur 
bestimmte Moleküle einer Signalkette untersuchen, bestimmen wir das Vorliegen von Chemokin-
RNA Transkripten in den verschiedenen Hirnbereichen im Zeitraum von der Geburt bis 28 Tage nach 
der Geburt. Zusätzlich interessieren uns die Unterschiede in der Chemokin-Expression zwischen 
wildtypischen Lewis-Ratten und PLP-transgenen Ratten, welche ein Myelin-Protein überexprimieren 
und dadurch Degenerationen in den Myelinscheiden aufweisen. Weiters untersuchen wir die 
Wirkung eines identifizierten, differentiell exprimierten Chemokines auf die Endothelzellen der Blut-
Hirn Schranke.
Diese Arbeit dient dazu, mehr Wissen über die kurzfristig erhöhte Anfälligkeit des Nervensystems für 
Entzündungsreaktionen zusammeln und um die Mechanismen aufzuklären, die zu einer Erhöhung 
der Permeabilität der Blut-Hirn Schranke führen.
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1Chapter 1
1. Introduction
This chapter gives an introduction to all topics regarding this 
diploma thesis. First, the general structure of the blood-brain 
barrier (BBB) and its functions under physiological and 
pathological circumstances is explained. Further topics that are
discussed are chemokines and chemokine receptors.
The mammalian brain is protected from its surroundings in different ways. The most obvious one is 
the skull, which shields against physical forces. Additionally, the brain is enclosed by the 
cerebrospinal fluid, which acts like a shock absorber protecting the brain from basic mechanical 
forces. However, the brain is shielded also from the own body’s blood system to avoid the 
uncontrolled influx of molecules and cells which could do harm to the brain (Prendergast and 
Anderton, 2009). Therefore, the brain is called an “immune privileged organ”. The shielding of the 
brain parenchyma is accomplished by the so-called blood-brain barrier (BBB) (see Figure 1). It 
comprises several cell types and protein meshworks that are all needed for a proper sealing of brain 
blood vessels.
Figure 1: The cellular basis of the blood-brain barrier. (A) Diagram of a brain capillary in cross section and 
reconstructed views, showing endothelial tight junctions, and the investment of the capillary by astrocytic 
end feet. (B) Electron micrograph of boxed area in (A), showing the appearance of tight junctions between 
neighboring endothelial cells (arrows). (A after Goldstein, Goldstein and Betz, 1986; B from Peters et al., 
1991.) 1
1 Modified picture and legend taken from http://www.daviddarling.info/images/blood-brain_barrier_2.jpg
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1.1. The Blood-Brain Barrier (BBB)
The BBB is made up of a complex system comprising multiple cell types and basement membranes.
Endothelial cells line the central nervous system (CNS) vasculature and form a very compact cell-
network that inhibits diffusion of many molecules across the BBB. The endothelial cell-cell junctions
that–under physiological circumstances–tightly seal the brain vasculature are tight junctions
(Wolburg and Lippoldt, 2002). Figure 2 shows the general composition of tight junctions, as well as 
adherence junctions that are considered to be less important in paracellular permeability (Breier et 
al., 1996). Tight junctions are complexes of transmembrane proteins (claudins, occludin, junction 
adhesion molecule A (JAM-A), endothelial cell-selective adhesion molecule (ESAM)) and cytoplasmic 
proteins (zone occludens 1-3 (ZO1-3), cingulin, Cask, 7H6) (Wolburg and Lippoldt, 2002). The latter 
ones link the transmembrane proteins to the cells’ actin cytoskeleton. Adherence junctions are made 
up of vascular endothelial-cadherin (VE-cadherin) (Dejana et al., 2008) which is linked to the actin 
cytoskeleton ?????-??????????-actinin, vinculin, and radixin. Apart from tight or adherence junctions, 
CD99 and PECAM-1 can be found within endothelial cell contacts. (Engelhardt and Sorokin, 2009)
Figure 2: Endothelial cell–cell junctions of CNS microvessels. The scheme shows the junctional molecules 
localized in the cell–cell contacts of CNS microvessels within tight junctions and adherens junctions and
outside of these organized junctions. Transmembrane junctional proteins (names mentioned in cell 1), 
scaffolding proteins and junction associated proteins involved in mediating the interaction with the actin 
cytoskeleton (cell 2) are depicted. Picture and parts of legend taken from Engelhardt and Sorokin, 2009.
Despite the tight sealing, delivery of nutrients into the brain parenchyma has to be provided. This 
transport across the blood-brain barrier occurs via different pathways. Usually, penetration of water-
soluble molecules is restricted by tight junctions (Figure 3/a). Lipid-soluble compounds can diffuse 
along the lipid membranes (Figure 3/b). For more complex substances, transport proteins are 
provided, which are partially energy-dependent (Figure 3/c). Receptor-mediated endocytosis and 
transcytosis (Figure 3/d) as well as adsorptive-mediated endocytosis and transcytosis (Figure 3/e)
constitute the additionally possible transport pathways (Abbott et al., 2006). Endothelial cells also 
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express efflux transporters, such as P-glycoprotein, which provide efficient transport of harmful 
substances out of the CNS (Nicolazzo and Katneni, 2009).
Figure 3: Pathways across the blood-brain barrier. A schematic diagram of the endothelial cells that form 
the blood–brain barrier (BBB) and their associations with the perivascular endfeet of astrocytes. The main 
routes for molecular traffic across the BBB are shown. Picture and parts of legend taken from Abbot et al., 
2006.
The endothelial cell monolayer is ensheathed by the endothelial basement membrane (BM) that is
further covered by the astroglial BM and the leptomeningeal BM, which together build up the so-
called parenchymal BM (Engelhardt and Sorokin, 2009). At the level of bigger vessels (venules and 
postcapillary venules), endothelial and parenchymal basement membranes are distinguishable by 
electron microscopy. In smaller vessels, brain capillaries, they are fused to one BM (Zhang et al., 
1990) (Engelhardt and Sorokin, 2009). Figure 4 shows an overview of the different BBB structures.
Figure 4: Cell and basement membrane layers of CNS blood vessels. Larger blood vessels consist of an 
inner endothelial cell layer with BM, bordered by the meningeal epithelium and its BM, and an outer 
astroglial BM and astrocyte endfeet. Meningeal and astroglial BMs are collectively termed the 
parenchymal BM as they delineate the border to the brain parenchyma. Modified picture and legend 
taken from Engelhardt and Sorokin, 2009.
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Different cell types can be found between or incorporated to the different basement membrane 
layers: Pericytes that might play an important role in BBB maintenance and transendothelial 
electrical resistance (Garberg et al., 2005) contribute to the endothelial BM. Between the endothelial 
and parenchymal basement membranes, perivascular antigen-presenting cells and perivascular 
macrophages are abundant (Hawkins and Davis, 2005). Leptomeningeal cells, epithelial cells of the 
pia mater and arachnoid mater, two of the meningeal membranes that surround the brain, are part 
of the leptomeningeal basement membrane (Zhang et al., 1990). Astrocytes contribute to the 
astroglial basement membrane with their so-called endfeet (Engelhardt and Sorokin, 2009). Figure 5
and Figure 6 show the localization of astrocytes and perivascular macrophages within cortical 
sections.
Figure 5: GFAP staining of cortical section. This 
staining shows the localization of astrocytes in 
brown color and the nuclei of all cell types 
present in this brain region in blue color. Cortical 
tissue is derived from a 21-day old Lewis rat.
Figure 6: Iba-1 staining of cortical section. This 
staining shows perivascular macrophages 
(arrows) and parenchymal microglia (arrowhead) 
in brown color and the nuclei of all cell types 
present in this brain region in blue color. Cortical 
tissue is derived from a 28-day old PLP-
transgenic rat.
The BBB basement membranes themselves are acellular layers consisting of mainly laminins, collagen 
type IV, heparan sulfate proteoglycans, and nidogens (Hallmann et al., 2005). Apart from the four 
main components, minor proteins such as basement membrane protein 40 (BM40), basement 
membrane protein 90 (BM90), collagen types VIII, XV, and XVII, and thrombospondin 1 and 2 (Timpl, 
1989) are incorporated in the endothelial BM. It was found that endothelial cells produce????????????
???? ???? ??????????????? ?????? ???????? ??? ???? ??????????? ???????? ?? (Sixt et al., 2001). Regarding 
heparan sulfate proteoglycan composition, perlecan is said to be the predominant one in the 
endothelial BM whereas agrin is mainly found in the parenchymal BM (Agrawal et al., 2006). At the 
?????????? ??????? ???????? ???? ???? ???? ?5 (b??? ??? ???????? ???? ???, additionally, perlecan and agrin 
contribute to the composite BM. 
Under physiological conditions, the BBB shields the CNS against water-soluble molecules and cells 
that would do harm. During inflammation, the integrity of the BBB is compromised and cell entry into 
the perivascular space and the CNS parenchyma occurs (Kielian et al., 2001). This is achieved by the 
combined action of several participants - amongst others chemokines, which tell cells where to go,
cytokines, which tell cells what to do, and adhesion molecules, which tell the cells where to enter.
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1.2. Window of Susceptibility
It is known that children, compared to adults, are at higher risk to experience persisting brain 
damage and death after head injury or infection (Anthony et al., 1998). In animal studies it has been 
shown that younger animals tend to develop acute, severely damaging responses more easily than 
adult ones (Anthony et al., 1998) (Galea et al., 2007) (Umehara et al., 1990). Additionally it was found 
that blood vessels of young rats are much more leaky than those of older ones (Schoderboeck et al., 
2009). This “window of susceptibility” in which young individuals are more susceptible to CNS 
inflammation than adults could be due to altered blood brain barrier properties and chemokine 
expression patterns. The different chemokine composition of rat brains in the course of time will 
therefore be in focus of this diploma thesis.
1.3. Chemokines
Chemokines belong to the large family of cytokines. More precisely, they are cytokines with 
chemotactic (= movement directing) functions: CHEMOtactic cytoKINES (Laing and Secombes, 2004).
They induce migration and activation of leukocytes under both, physiological and pathological 
circumstances (Bajetto et al., 2001). Some are involved in immune surveillance and homeostasis. 
Others are only produced due to proinflammatory stimuli, and trigger as well as modify immune 
responses (Fernandez and Lolis, 2002).
Chemokines are rather small (8-14kD) and share structural similarities (Ubogu et al., 2006). Their 
sequence identities vary from 20% to over 90% (Fernandez and Lolis, 2002). They usually harbor four 
invariant cysteine residues (Laing and Secombes, 2004) (Bajetto et al., 2001). The first, which is 
closest to the N-terminus, and the third cysteine are connected to each other via a covalent bond. 
The same holds true for the second and the fourth cysteine (see Figure 7) (Fernandez and Lolis, 
2002).
1.3.1. Classification of Chemokines
Chemokines have a well defined secondary structure. A rather unstructured N-terminus that harbors 
2 cysteine residues is followed by a stretch of approximately 10 amino acids, the so-called N-loop, 
which has an important functional role in receptor specificity and binding. The N-loop is terminated 
by a single-turn helix, which is followed by ????????????????????-strands. The??-strands are connected 
by turns, better known as 30s, 40s, and 50s loops. The 30s and 50s loops harbor the third and fourth 
cysteine, respectively. At the C-????????? ??? ???????????? ??? ?-helix is located (see Figure 7)
(Fernandez and Lolis, 2002) (Crump et al., 1999).
Based on their primary structure (= amino acid sequence), chemokines can be divided into four 
subfamilies (Laing and Secombes, 2004) (Bajetto et al., 2001). If the two N-terminal cysteines are 
adjacent to each other, the chemokines belong to the CC chemokine subfamily. If there are one or 
three intervening amino acids between the first two cysteines, they are subclassified as CXC 
chemokines or CX3C chemokines, respectively (Fernandez and Lolis, 2002). Members of the C 
chemokine subfamily contain only one N-terminal cysteine and also lack the corresponding third 
cysteine (Laing and Secombes, 2004). Some chemokines of the CC-subfamily possess six cysteines, 
which are also covalently linked (C6-CC chemokines) (Fernandez and Lolis, 2002). Figure 8 shows a 
schematic overview of the structure and disulphide bonds in each chemokine subfamily. 
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Figure 7: 3-D structure of chemokines2
Figure 8: Structure of chemokine classes3
• C chemokines
This subfamily contains two members: XCL1 and XCL2. These chemokines consist of only 2 
cysteine residues as they lack the first N-terminal cysteine and its corresponding third cysteine. 
XCL1 and XCL2 both act on the same receptor, XCR1, and induce chemotaxis of lymphocytes
(see Table 1) (Laing and Secombes, 2004).
Name Common name Receptor
XCL1 Lymphotact???? XCR1
XCL2 Lymphotactin ß XCR1
Table 1: Summary of known C chemokines4
• CC chemokines
Five chemokines of this subfamily contain 6 cysteine residues: CCL1, CCL15, CCL21, CCL23, and 
CCL28 (Laing and Secombes, 2004).
2 Taken from http://commons.wikimedia.org/wiki/File:ChtxChemkinStr2.png
3 Taken from http://commons.wikimedia.org/wiki/File:ChtxChemokineStruct.png
4 Combined from Laing and Secombes, 2004; Ono et al., 2003; and Fernandez and Lolis, 2002.
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The CC chemokines can be further divided into five subgroups: Pro-inflammatory, allergenic, 
HCC (haemofiltrate CC), homeostatic, and developmental. Members of the homeostatic and 
developmental subgroups are said to be constitutively expressed, expression of members of 
the other subgroups is inducible (Laing and Secombes, 2004). Allergenic chemokines attract 
eosinophils or basophils, and some can trigger basophil degranulation/ histamine release. Some 
of them are also monocyte and T-cell attractants. Pro-inflammatory and HCC chemokines 
participate in inflammatory processes. The cell types that they act on differ. Homeostatic 
chemokines are constitutively produced in lymphoid tissue where they are said to play roles in 
homing of T cells and mature dendritic cells. Developmental chemokines are known to be
expressed in the thymus and can chemotactically act on dendritic cells, monocytes and 
thymocytes (see Table 2) (Laing and Secombes, 2004).
Name Common name Receptor Subgroup
CCL1 I-309, TCA-3 CCR8 Allergenic
CCL2 MCP-1 CCR2, CCR2 Allergenic
CCL3 MIP-1a CCR1 Pro-inflammatory
CCL4 MIP-1ß CCR1, CCR5 Pro-inflammatory
CCL5 RANTES CCR1, CCR3, CCR5 Pro-inflammatory
CCL6 C10 CCR1 Pro-inflammatory
CCL7 MARC, MCP-3 CCR2 Allergenic
CCL8 MCP-2 CCR1, CCR2B, CCR5 Allergenic
CCL9/CCL10 MIP-?? CCR1
CCL11 Eotaxin CCR2, CCR3, CCR5 Allergenic
CCL12 MCP-5 Allergenic
CCL13 MCP-4 CCR2, CCR3, CCR5 Allergenic
CCL14 CC-1 CCR1 HCC
CCL15 Leukotactin-1 CCR1, CCR3 HCC
CCL16 LEC CCR1, CCR2, CCR5, CCR8 HCC
CCL17 TARC CCR4 Developmental
CCL18 PARC Pro-inflammatory
CCL19 ELC CCR7 Homeostatic
CCL20 LARC CCR6 Homeostatic
CCL21 SLC CCR7 Homeostatic
CCL22 MDC CCR4 Developmental
CCL23 MPIF-1 CCR1 HCC
CCL24 MPIF-2, Eotaxin-2 CCR3 Allergenic
CCL25 TECK CCR9 Developmental
CCL26 Eotaxin-3 CCR3 Allergenic
CCL27 ESkine, PESKY CCR10
CCL28 MEC CCR3, CCR10
Table 2: Summary of known CC chemokines5
• CXC chemokines
This subfamily can be further divided into 2 subgroups depending on the existence of a three 
amino acid motif (glutamat-leucine-arginine, ELR) adjacent to the CXC motif.
5 Combined from Laing and Secombes, 2004; Ono et al., 2003; and Fernandez and Lolis, 2002.
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ELR+ CXC chemokines favor the adherence of neutrophils to endothelial cells. They are also said 
to be angiogenic and chemotactic for endothelial cells. In rats, ELR+ chemokines act on two 
receptors: CXCR1 and CXCR2 (see Table 3). Additional target cells of this chemokine subgroup 
are mainly basophils, eosinophils, and partly peripheral blood T lymphocytes, fibroblasts, NK 
cells, and megakaryotes. CXCL8 has not been found in mice and rats (Laing and Secombes, 
2004).
Name Common name Receptor
CXCL1 GRO???????????? CXCR2
CXCl2 GROß, Cinc3 CXCR2
CXCL3 ??????????? CXCR2
CXCL5 ENA-78 CXCR2
CXCL6 GCP-2 CXCR1, CXCR2
CXCl7 NAP-2
CXCl8 IL-8 CXCR1, CXCR2
CXCL15 Lungkine
Table 3: Summary of known ELR+ CXC chemokines6
ELR- CXC chemokines have a poor chemotactic influence on neutrophils but are highly involved 
in attraction of lymphocytes and monocytes. Besides CXCL12, which has angiogenic properties, 
the members of the ELR- subfamily trigger mostly angiostatic or anti-angiogenic activities (see 
Table 4) (Laing and Secombes, 2004).
Name Common name Receptor
CXCL4 PF-4 CXCR3B
CXCl9 MIG CXCR3
CXCl10 IP-10 CXCR3
CXCL11 I-TAC CXCR3
CXCl12 SDF-1 CXCR4
CXCl13 BCA-1 CXCR5
CXCL14 BRAK
CXCl16 CXCR6
Table 4: Summary of known ELR- CXC chemokines7
• CX3C chemokines
The CX3C subfamily has only one member: CX3CL1. This chemokine is usually membrane 
attached and induces adhesion of leukocytes. The soluble form acts as a chemoattractant for T 
cells and monocytes (see Table 5) (Laing and Secombes, 2004).
Name Common name Receptor
CX3CL1 Fractalkine CX3CR1
Table 5: CX3C chemokines
8
6 Combined from Laing and Secombes, 2004; Ono et al., 2003; and Fernandez and Lolis, 2002.
7 Combined from Laing and Secombes, 2004; Ono et al., 2003; and Fernandez and Lolis, 2002.
8 Combined from Laing and Secombes, 2004; Ono et al., 2003; and Fernandez and Lolis, 2002.
Introduction
9
1.3.2. Chemokine Receptors
Chemokine receptors belong to the family of G protein-coupled receptors that span the lipid bilayer 
with their seven transmembrane domains. They consist of approximately 250 amino acids and have a 
relatively short, acidic, extracellular N-terminus and a short intracellular C-terminus (Ono et al., 
2003). Different signaling cascades can be elicited upon receptor stimulation (see Figure 9).
Figure 9: Chemokine receptor signaling9
Some receptors bind multiple chemokines, others bind fewer. Similarly, some chemokines bind to 
several receptors (Bajetto et al., 2001). One receptor, the Duffy antigen receptor, is even able to bind 
chemokines of different chemokine families (Ono et al., 2003). It is known that the chemokine 
receptor expression pattern on cells can change during differentiation or due to external stimuli. It is 
also important to note that some cell types (amongst others also endothelial cells) express both: 
chemokines and their receptors. This can lead to e.g., signal amplification during inflammatory 
responses (Ono et al., 2003).
In this diploma thesis, we will study the chemokine expression profiles of wild-type and proteolipid 
protein overexpressing transgenic Lewis rats. Since the latter animals have a low grade myelin 
degeneration throughout life, a short information about myelin will be given. 
9 Taken from http://www.sabiosciences.com/pathway.php?sn=Chemokine_Signaling
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1.4. Myelin
In order to enable fast action potential transmission, axons are ensheathed by an electrical insulator 
called myelin. Myelin sheaths comprise multiple wrappings of lipid bilayers containing different
membrane spanning proteins (Jahn et al., 2009). The most abundant ones in compact CNS myelin are 
proteolipid protein (PLP), myelin basic protein (MBP), connexin 32 (Cx32), myelin associated 
glycoprotein (MAG), and myelin oligodendrocyte protein (MOG) (Quarles, 1997). The latter is found 
only in the outermost sheath. In the CNS, myelin sheaths are formed by oligodendrocytes (Baumann 
and Pham-Dinh, 2001), whereas in the PNS, Schwann cells are responsible for myelination. Generally, 
the myelin sheath does not cover the whole axon as there are small regions, called nodes of Ranvier,
which regularly interrupt the ensheathment. The region between two nodes of Ranvier is called the 
internode. In the CNS, one oligodendrocyte myelinates several internodes whereas in the PNS, one 
Schwann cells ensheathes just one internode (see Figure 10).
Figure 10: Myelinating glial cells, myelin structure, and composition in the PNS and CNS. In the PNS, the 
myelinating Schwann cell myelinates only one segment of axon (top left corner), whereas in the CNS (top 
right corner), the oligodendrocyte is able to myelinate several axons. The myelin proteins are 
schematically described; they differ between PNS and CNS. Picture and parts of legend taken from 
Baumann N. and Pham-Dinh D., 2001.
The proteolipid protein (PLP) is a four-transmembrane domain protein of central nervous myelin. PLP 
molecules bind to each other, tightly hold the myelin layers together, and therefore play a role in 
compaction and maintenance of the myelin sheath (Baumann and Pham-Dinh, 2001). PLP accounts 
for approximately 50% of the myelin protein content. The PLP gene is located on the X-chromosome 
and mutations (either duplications, deletions, missense mutations, etc.) cause X-linked Pelizaeus-
Merzbacher disease (Wolf et al., 2005) and spastic paraplegia type 2.
As mentioned above, we used PLP overexpressing transgenic rats in our study. Homozygous PLP-
transgenic rats die early in life and have tremors and seizures, whereas hemizygous animals do not 
Introduction
11
show abnormal phenotypes and are viable (Bradl et al., 1999). In PLP hemizygous rats, there is no 
CNS dysmyelination and massive oligodendrocyte death, but these animals show low-grade, sub-
clinical myelin degeneration throughout their lives, which results in astrocyte and microglia 
activation (Bradl et al., 1999) (Bauer et al., 2002). Overexpression of PLP is known to elicit 
endoplasmic reticulum (ER) stress within oligodendrocytes (Gow et al., 1994) (Casaccia-Bonnefil, 
2000), which disables proper cell functioning.
1.5. Questions to Be Solved
We want to examine whether there are differences in chemokine expression patterns observable in 
different CNS regions at different time points during rat development. We will not only examine wild-
type Lewis rats, but also use PLP overexpressing Lewis rats. This comparison is supported by a 
detailed histochemical characterization of the hemizygous PLP-transgenic rats.
Another part of this work will focus on endothelial cell cultures. Years ago, freshly isolated rat brain 
endothelial cells were already cultured in our lab, however, isolation method and culturing 
conditions have to be enhanced. We will then use one of the differentially expressed chemokines 
(CXCL2) to study its effect on endothelial cells of the blood-brain barrier in vitro.
12
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Chapter 2
2. Material and Methods
This chapter gives detailed information about the applied 
methods and the required material. Methods or parts of certain 
procedures that were done by other people (technicians and 
collaboration partners) are only mentioned and not described 
in detail.
This diploma thesis consisted of three subprojects. The different technologies needed for these 
different subprojects are summarized below:
• Characterization of the Postnatal Brain Development of Wild-type and Hemizygous PLP-
Transgenic Lewis Rats
- Genotyping of Hemizygous PLP Transgenic Lewis Rats
- Tissue Sampling & Immunohistochemistry
• Analysis of the Global Chemokine Expression Patterns at Different Time Points of Postnatal
Brain Development
- RNA Isolation from Animal Tissue and Cultured Cells
- Pathway-Focused Microarray
• Establishment of Rat Brain Endothelial Cell Cultures and Testing of Their Response to
Chemokines Produced During Postnatal CNS Development
- Collagen-Coating of Cell Culture Dishes
- Isolation and Culturing of Rat Brain Endothelial Cells
- Immunocytochemistry of Rat Brain Endothelial Cells
- Pathway- Focused Real-Time PCR Analysis of Chemokine Treated Endothelial Cells
Material and Methods
14
2.1. Genotyping of Hemizygous PLP Transgenic Lewis Rats
2.1.1. Material
• DNeasy Blood & Tissue Kit (Qiagen)
• FastStart Taq DNA Polymerase dNTPack (Roche)
• Forward Primer “Cos 901 For”
Sequence: 5’-CAG-GTG-TTG-AGT-CTG-ATC-TAC-ACA-AG-3’
GC-content: 46.2%
Melting point: 63.2°C
• Reverse Primer “Cos 901 Rev”
Sequence: 5’-GCA-TAA-TAC-GAC-TCA-CTA-TAG-GGA-TC-3’
GC-content: 42.3%
Melting point: 61.6°C
• LE Agarose (Biozym)
• 50X TAE buffer (Tris-Acetate-EDTA electrophoresis buffer)
2M Tris
50mM EDTA
2M glacial acetic acid
Dissolve solids in approx. 900ml ddH2O and adjust pH to 7.6-7.8 with HCl.
Fill up with ddH2O to 1000ml.
• 1X TAE
Dilute 50X TAE buffer for electrophoresis.
• Ethidium bromide solution 10mg/ml (Sigma)
• peqGold 100bp DNA ladder (PeqLab)
• RNase free H2O (Ampuwa®)
• 96%-100% EtOH
2.1.2. Method
Wild-type (wt) Lewis and hemizygous PLP-transgenic (tg) Lewis rats were bred in the Decentral 
Facilities of the Institute for Biomedical Research (Medical University Vienna). Since our line of PLP-
transgenic Lewis rats was maintained by breeding hemizygous transgenic males with wild-type 
females, it was necessary to identify wild-type and PLP-transgenic pups by PCR. For this purpose, 
3mm of the pups' tail tips were cut off within the first three weeks after birth. Using “DNeasy Blood 
& Tissue Kit” and following the manufacturer’s protocol “Purification of Total DNA from Animal 
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Tissues; Spin-Column Protocol”, the tail tips were lysed and DNA was isolated. After eluting isolated 
DNA in 100µl AE buffer (provided by DNeasy Blood & Tissue Kit), PCR was carried out using FastStart 
Taq DNA Polymerase dNTPack and the Cos901 forward and reverse primers. 
The following PCR cycles were run:
1) 10’ 95°C Initial Denaturation Step
2) 40x 30’’ 95°C Denaturation Step
30’’ 56.5°C Primer Annealing Step
30’’ 72°C Extending Step
3) 10’ 72°C Final Extending Step
4) 4°C Cool-Down
The PCR products were loaded on 2% agarose gels and run for 60 minutes at 100V. Using Gel Doc 
2000 and Quantity One (both Bio-Rad), the gels were examined. If rats were transgenic, a band of 
approx. 350bp was visible. In the case of wild-type rats, no PCR products were generated.
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2.2. RNA Isolation from Animal Tissue and Cultured Cells
2.2.1. Material
• RNeasy Mini Kit (Qiagen)
• 10X Reaction Buffer with MgCl2 (Fermentas)
• RiboLockTM RNase Inhibitor (Fermentas)
• DNase I (Fermentas)
• 25mM EDTA (Fermentas)
• RNase free H2O (Ampuwa®)
• 70% EtOH
• 100% EtOH
2.2.2. Method
Rat brain endothelial cells, grown in 35x10mm dishes, were washed three times with PBS. Then 
4????? ??? ???? ??????? ?????????? ????? ????? ?-mercaptoethanol per 1ml buffer) were added and 
dispersed. Successful lysis of cells resulted in highly increased viscosity of the RLT buffer. The whole 
suspension was later transferred to a QIAshredder spin column and centrifuged for 2 minutes at full 
speed. Thereafter, RNA was isolated using the “RNeasy Mini Kit” according to the manufacturer’s 
instructions (Protocol: “Purification of Total RNA from Animal Tissue”).
The RNA of the postnatal rat brain derived from three different sources: The cerebral cortex, 
cerebellum, and the brain stem. In Addition, RNA was also isolated from the spinal cords. The tissue 
was pooled from 3-6 rats, using equal amounts of starting material. 
Immediately after tissue dissection, the tissue was frozen at -80°C until further usage. The frozen 
tissue samples ????????????????? ???????????????????? ?????????????????????-mercaptoethanol per 
1ml buffer) using a rotor-stator homogenizer (Miccra D-1 dispersing and homogenizing device, ART-
moderne Labortechnik). The homogenate was transferred into two QIAshredder spin columns and 
centrifuged for 2 minutes at full speed. Thereafter, RNA isolation was done according to the 
instructions of the manufacturer using the "RNease Mini Kit".
In both cases, the RNA was eluted in 50µl RNase-free water.
Immediately after the RNA isolation, contaminating genomic DNA was removed using appropriate 
enzymes and buffers purchased from Fermentas. To 50µl RNA solution the following mix was added:
10X Reaction Buffer with MgCl2 7µl
RiboLockTM RNase Inhibitor 2µl
DNase I 7µl
RNase-free water 4µl
Total volume 20µl
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DNA digestion was done at 37°C. After 30 minutes, 7µl 25mM EDTA were added to each sample and 
the mixture was further incubated at 65°C for 10 minutes.
The resulting DNA free RNA samples were purified according to the “RNA Cleanup” protocol, again 
using the “RNeasy Mini Kit”. This time the RNA was eluted in 30µl RNase-free water.
Afterwards, RNA concentration and purity were determined by UV-VIS spectrophotometric analysis 
using NanoDrop 2000 (Thermo Scientific). For each analysis absorbances at 230nm, 260nm, and 
280nm were measured. The RNA concentrations were calculated according to the following 
equation: 
RNA concentration = 40 x A260nm x dilution factor
Generally, the 260nm/280nm absorbance ratio is used to assess the RNA purity. Values of 2.0 
indicate pure RNA without DNA and protein contamination. The ratio of absorbance at 260nm and 
230nm gives a hint for carbohydrate or EDTA contamination within the RNA sample. 260/230 values 
of 2.0 to 2.2 indicate pure RNA without any contaminations that absorb at 230nm (carbohydrates 
and also reagents that are usually used during RNA or DNA isolation: EDTA, TRIzol reagent or 
guanidine HCl). Ratios below 2.0 indicate contamination by the latter reagents that might influence 
all following experiments. 
Finally, after assessment of RNA concentration and purity, the RNA samples were stored at -80°C
until further usage.
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2.3. Pathway-Focused Microarray
In principle the microarrays used resemble Northern blots that are usually used to study gene 
expression at mRNA level. In contrast to Northern blots, we did not blot RNA on our own but 
purchased the following pathway-focused microarrays: Oligo GE Array® Rat Chemokines & 
Receptors, ORN-022 (SABiosciencesTM). These microarrays consist of a 3.8 x 4.8cm nylon membrane 
with pre-spotted RNA at 128 positions (see Figure 11). The arrays were pathway-focused, which 
means that we did not have to examine the whole mRNA content of the tissue but could concentrate 
on the gene expression patterns relevant for our studies. Apart from some housekeeping genes and 
controls, the 128 positions on the array cover the most important chemokines and chemokine 
receptors.
For hybridization of isolated mRNA with the RNA spotted on the array membrane, we used the 
GEArray® HybTube format as a hybridization oven was already available in the lab. Hence, the 
purchased microarrays were rolled up in so-called HybTubes (see Figure 12) for hybridization and 
development. Only at the end, for image acquisition, the arrays had to be taken out.
Figure 11: GEArray® Microarray 10 Figure 12: GEArray® HybTube11
2.3.1. Material
• Oligo GE Array® Rat Chemokines & Receptors Microarray, ORN-022 (SABiosciencesTM)
• Oligo GEArray® Reagent Kit (SABiosciencesTM) that consists of:
TrueLabeling-AMP™ 2.0 Kit
ArrayGrade™ cRNA Cleanup Kit
Hybridization Solution
Chemiluminescent Detection Kit
• Biotin-16-UTP, 10mM (Roche)
• Kodak® GBX developer/replenisher (Sigma)
• Kodak® GBX fixer/replenisher (Sigma)
10 Picture taken from „Oligo GEArray® System” User Manual; SABiosciences (http://www.sabiosciences.com)
11 Picture taken from a GEArray® Brochure; SABiosciences (http://www.sabiosciences.com)
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• Kodak® BioMaxTM light films (Sigma)
• RNase free H2O (Ampuwa®)
• 70% EtOH
• 100% EtOH
2.3.2. Method
The “Pathway-Focused Micro-Array” protocol can be divided into four different parts:
• Tissue preparation
Wild-type and hemizygous PLP-transgenic Lewis rats were sacrificed by inhalation of an 
overdose of CO2. Cerebral cortex, cerebellum, brain stem (with medulla oblongata), and spinal 
cord were excised immediately. Each tissue part was stored in an individual tube; cortex and 
cerebellum were usually split in two tubes as enough tissue was available. The samples were 
immediately stored on dry ice and later at -80°C until further usage.
Tissue was taken at five different developmental time points: Postnatal days (P) 0, 7, 14, 21, 
and 28. Depending on the available amount of rats, tissue was used from 3 to 6 animals per 
time point and genotype. 
• RNA isolation
For each time point (P0, P7, P14, P21, P28) and genotype (Lewis wild-type, PLP-transgenic), 
samples containing the same tissue types (cerebral cortex, cerebellum, brain stem (with 
medulla oblongata) or spinal cord) were pooled. Small pieces of frozen tissue were cut, and 
combined according to tissue type and genotype. 60mg in total were homogenized in 1200µl 
RTL-????????????????????????????-mercaptoethanol per 1ml buffer) prior to RNA isolation which 
was done as described in Chapter 2.2.
• cRNA transcription
The isolated RNA was transcribed into cDNA that was used to produce biotin-UTP-labeled cRNA 
probes using the “TrueLabeling-AMPTM Kit” according to the instructions of the manufacturer.
• Hybridisation
First, the pathway-focused microarrays "Oligo GE Array® Rat Chemokines & Receptors, ORN-
022" had to be prehybridized over night with hybridization solution. The next day, cRNA 
samples were first purified using “ArrayGrade™ cRNA Cleanup Kit“ as specified by the 
manufacturer, added to the corresponding HybTubes, and hybridized for approximately 17 
hours at 60°C in a hybridization oven. Afterwards, the microarrays were developed, using the
“Chemiluminescent Detection Kit” and exposed to imaging films. Exposure times varied 
between 1 minute and 1 hour. For data evaluation, images with comparable housekeeping 
gene (Ppia and Rpl32) signals were used.
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2.4. Collagen-Coating of Cell Culture Dishes
2.4.1. Material
• 0.1% Collagen type-I solution from calf skin (Sigma)
• Cell culture dish, 35x10mm (Greiner bio-one)
• Cell culture multiwell plate, 6 wells (Greiner bio-one)
2.4.2. Method
The 0.1% collagen type-I solution was further diluted with sterile water to a final concentration of 
0.01% (= 0.1g calf skin collagen/ml).
In the evening before endothelial cell isolation, 1ml of the 0.01% collagen solution was added either 
to 35x10mm dishes or wells of a 6-well plate. With closed lids, the collagen was exposed to UV-light 
overnight. The next morning, lids were opened and collagen was allowed to dry in a sterile tissue 
culture hood. Before seeding cells, the dishes/ wells were rinsed twice with sterile PBS.
Usually, such coated dishes/ wells were used the next day after overnight coating.
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2.5. Isolation and Culturing of Rat Brain Endothelial Cells
2.5.1. Material
• Buffer A (pH 7.4, in PBS, sterile filtered)
153mM NaCl (Merck)
5.6mM KCl (Merck)
2.3mM CaCl2 2H2O (Merck)
2.6mM MgCl2 6H2O (Riedel de Häen)
15mM Hepes (Sigma)
Adjust pH by adding NaOH.
Finally add 10mg/ml BSA (PAA).
• Collagenase (in PBS, sterile filtered)
0.75% Collagenase (Type: CLS II, 283U/mg, Biochrom AG)+ 0.1% BSA (PAA)
• 25% BSA (in Buffer A, sterile filtered)
• DMEM/ 10% FCS
• Percoll 50 (sterile filtered)
22.5ml Percoll, density: 1.132g/ml (GE Healthcare)
2.5ml DMEM (Lonza)
25ml DMEM/10% FCS
• Endothelial Cell Medium, without L-Glutamine (PAA)
• 0.1mg/ml working solution of puromycin dihydrochloride, from Streptomyces alboniger (Sigma)
• Hydrocortisone (Sigma)
• Recombinant human FGF basic 146aa, E. coli derived (R&D Systems)
• L-Glutamine, 200mM (BioWhittaker®, Lonza)
• Penicillin-Streptomycin, 10000U Potassium Penicillin/ml, 10000µg Streptomycin Sulfate/ml 
(BioWhittaker®, Lonza)
• Collagen-coated cell culture dishes/ well plates (see Chapter 2.4)
2.5.2. Method
Adult Lewis rats (age usually varied between 7 and 9 weeks) were sacrificed, decapitated, and the 
heads immediately washed in 70% EtOH. The brains were dissected and stored in a dish filled with 
ice-cold PBS. Afterwards, the brains were washed in Buffer A; meninges, white matter, and 
cerebellum were removed. The cerebral cortices were transferred into a dish filled with 5ml PBS and 
cut into small pieces using razor blades and scalpels, and subsequently triturated using a 10ml 
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pipette. The resulting cell suspension was transferred to a 50ml tube and the dish washed with 2ml 
PBS. After centrifugation (1100rpm, 5 minutes, 20°C) the supernatant was discarded and the pellet 
resuspended in 5ml Buffer A and 5ml 0.75% collagenase. During the subsequent incubation (90 
minutes at 37°C) the homogenate was shaken every 10 minutes to ensure sufficient collagenase 
digestion. Digestion was stopped by adding Buffer A to a total volume of 40ml to 45ml. After 
centrifugation (1100rpm, 5 minutes, 4°C), the supernatant was discarded and the pellet was 
resuspended in 15ml 25% BSA. The homogenate was again centrifuged (2600rpm, 20 minutes, 4°C) 
resulting in the “1st BSA-gradient”. The upper phases were decanted into a new 50ml tube and 
centrifuged again (2600rpm, 20 minutes, 4°C) resulting in the “2nd BSA-gradient”. This time the
supernatant was discarded and each of the two pellets (from 1st and 2nd BSA-gradients) were 
resuspended in 5ml 0.75% collagenase. After 90 minutes incubation at 37°C, both tubes were 
centrifuged (1200rpm, 5 minutes, 20°C), the supernatant was discarded and the pellets were 
resuspended in 1ml DMEM/10% FCS. During the last collagenase digestion, two Percoll 50 gradients 
were prepared via centrifugation. For this purpose, two 30ml Corex glass tubes, 2 dark-blue SS-34 
adaptors and a SS-34 rotor were needed. Centrifugation was carried out in a Sorvall RC5C centrifuge. 
14ml Percoll 50 were added per Corex-tube which were afterwards sealed with Parafilm. Both tubes 
and adaptors were weighed and if necessary, the amount of Percoll 50 was adjusted for balancing. 
The gradients were established by 1 hour centrifugation at 14500rpm and room temperature (20°C) 
without brakes. The tubes had to be taken out in time and stored in an upright position. After 
resuspension of both cell pellets in 1ml DMEM/10% FCS, the suspensions were transferred with 
caution onto the Percoll 50 gradients. Afterwards, they were centrifuged using the Sorvall RC5C 
centrifuge (2600rpm, 10 minutes, 20°C). After centrifugation one or several dense, grey rings were
visible. Approximately 8ml of the fluid above, below, and between the layers were transferred into 
new 50ml tubes and the double volumes of DMEM/ 10% FCS were added. After centrifugation 
(1800rpm, 5 minutes, 20°C) the supernatant was discarded and 10ml DMEM/ 10% FCS were added. 
This time, the pellet was not resuspended but immediately centrifuged (1200rpm, 5 minutes, 20°C). 
The supernatant was again discarded and the pellet resuspended in Endothelial Cell Medium. Both 
aliquots were pooled and split into collagen-coated dishes or well-plates, which had been previously 
washed with PBS. To obtain pure endothelial cell cultures, 4µg or 3µg or puromycin (40µl or 30µl of 
0.1mg/ml working solution per 1ml Endothelial Cell Medium) (Perrière et al., 2005) were added and 
cells were grown for 2 or 3 days, respectively. Usually, 1.5ml medium were added per 35mm dish or 
well (6-well plate).
Two or three days after cell isolation (depending on the puromycin concentration used), the 
puromycin containing medium had to be discarded. Therefore, the old medium was aspirated, cells 
were washed three times with PBS and 1.5ml Endothelial Cell Medium were added per dish or well.
2ng/ml basic fibroblast growth factor and 500ng/ml hydrocortisone were added to the medium 
(Perrière et al., 2005). Usually, medium was changed every second day.
Pictures of growing cells were made with Axiovert 40 C microscope (Zeiss). 10-times (A-Plan 10X/0.25 
Ph1, Zeiss) and 20-times (LD A-Plan 20X/ 0.30 Ph1, Zeiss) magnifications and Ph1-0.4 aperture were 
used and photos were taken with Power Shot A650IS (Canon).
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2.6. Immunocytochemistry of Rat Brain Endothelial Cells
2.6.1. Material
• Coverslip 21x26mm (Carl Roth)
• 0.2M Sörensenbuffer (pH 7.4)
40mM NaH2PO4
160mM Na2HPO4
• 1X PBS
8,766g NaCl (150mM) dissolved in 250ml Sörensenbuffer and 750ml ddH2O.
• 4% PFA
40g PFA dissolved in heated 500ml 0.2M Sörensenbuffer. Fill up to 1l with ddH2O.
• 0.1% Triton X-100 (Sigma) in PBS
• Dako-diluent blocking solution (Dako)
• 1st antibodies
?- Von Willebrand factor, rabbit-anti-rat, 1:100 (Neomarkers)
?- ZO-1 (zonula occludens), rabbit-anti-rat, 1:50 (Zymed)
Ox-7 ??-Thy1), mouse-anti-rat, 1:250 (Serotec)
Ox-?????-transferrin receptor), mouse-anti-rat, 1:100 (Serotec)
• 2nd antibodies used for single color stainings
Biotinylated donkey-?-rabbit, 1:1000 (Jackson ImmunoResearch)
Biotinylated donkey-?-mouse, 1:250 (Jackson ImmunoResearch)
• 3rd antibodies used for single color stainings
Streptavidin-Cy3, 1:100 (Jackson ImmunoResearch)
• 2nd antibodies used for double color stainings
Donkey-?-mouse-Cy2, 1:200 (Jackson ImmunoResearch)
Goat-?-rabbit-Cy3, 1:100 (Jackson ImmunoResearch)
• DAPI (Roth)
• Geltol
6g glycerine
2.4g mowiol
6ml dH2O
12ml Tris 0.2M pH 8.5
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Stir for 10’ at 50°C. Then centrifuge at 5000 x g for 15’.
• 0.1M Gallate (in Geltol)
2.6.2. Method
Endothelial cells grown in collagen-coated cell culture dishes (35x10mm) or wells (6-well plate) were 
washed with PBS to remove remaining medium. Afterwards the cells were fixed with 4% PFA for 1.5
minutes, washed three times with 1X PBS for 5 minutes, and permeabilized with 0.1% Triton X-100 
for 5 minutes. Then the cells were again washed three times with 1X PBS for 5 minutes and blocked 
with Dako-diluent blocking solution for 30 minutes. In the meanwhile, primary antibody dilutions 
were prepared in PBS/ 10% Dako-diluent. 150 µl of each solution were pipetted on the 
corresponding dish and covered with a cover slip. The position of the cover slip was marked on the 
dish’s bottom. Incubation with primary antibodies was done over night at 4°C in a moist chamber. On 
the next day, the cells were washed three times with 1X PBS for 5 minutes and incubated for 60 
minutes at room temperature with the corresponding secondary antibodies. They were diluted in 
Dako Buffer/ 10% FCS and again 150?l per dish were applied. For this incubation the cells were again 
covered with a cover slip which was put onto the cells at the same position as done for the first time. 
After incubation cells were washed three times with 1X PBS for 5 minutes. If biotinylated 2nd
antibodies were used, an additional incubation for 45 minutes at room temperature with 150?l of 
streptavidin coupled to the fluorophor Cy3 (again diluted in Dako Buffer/ 10% FCS; again a cover slip 
was put onto the cells) was necessary. Then the cells were washed three times with 1X PBS for 5 
minutes and afterwards they were incubated with DAPI for 5 minutes. Before mounting the cells in 
one drop of Gallate/ Geltol, they were washed once with 1X PBS for 5 minutes and rinsed with 
ddH2O. The coverslip covered dishes were stored over night at 4°C. After 12 to 24 hours, the dishes’ 
walls were cut off with a hot scalpel. Until microscopy the dishes were stored in aluminum foil at 4°C.
Cells were examined at Leica TCS SP5 LASAF microscope (Leica Microsystems, CMS-GmbH, Germany). 
For detection of Cy2 signals an argon-laser (488nm excitation), for Cy3 signals a DPSS561 laser and 
for DAPI staining a 405 Diode laser were used.
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2.7. Pathway- Focused Real-Time PCR Analysis of Chemokine 
Treated Endothelial Cells
2.7.1. Material
• CXCL2 (PeproTech)
• RT2 First Strand Kit (SABiosciencesTM)
• RT2 SYBR Green/ ROX qPCR Master Mix (SABiosciencesTM)
• RT2 ProfilerTM PCR Array, Rat Endothelial Cell Biology, PARN-015C (SABiosciencesTM)
• RNase free H2O (Ampuwa®)
2.7.2. Method
For chemokine treatment, 5-day old primary rat brain endothelial cell cultures (treated for 2 days 
with 4µg/ml puromycin, grown in 35x10mm cell culture dishes) were washed once with PBS. 
Afterwards, the cells were incubated for 6 hours with either 10ng/ml CXCL2 or with plain endothelial 
medium without any stimulants (= control). After puromycin treatment the cultures were grown in 
endothelial medium enriched with 2ng/ml basic fibroblast growth factor and with 500ng/ml 
hydrocortisone. During chemokine treatment, these supplements were omitted. As our medium did
not contain serum, serum starvation prior to chemokine treatment was not necessary.
After chemokine treatment cells were washed three times with PBS and lysed in 400µl RLT buffer 
?????????? ????? ????? ?-mercaptoethanol per 1ml buffer). Thereafter RNA was isolated and RNA 
concentration was measured (see Chapter 2.2).
For cDNA transcription approximately 700ng RNA were used. We used the “RT2 First Strand Kit” for 
reverse transcription and followed the manufacturer’s instructions. Afterwards, transcribed cDNA 
was mixed with “RT2 SYBR Green/ ROX qPCR Master Mix” and loaded in a 96-well PCR Array with 
help of a multichannel pipette. Using the Step One Plus Real-Time PCR machine (Applied Biosystems), 
the following PCR cycles were run:
Cycles Duration Temperature
1 10’ 95°C
40x 15’’ 95°C
1' 60°C
Thereafter, a melting curve program was run according to the instrument-specific melting curve 
settings.
After each RT-PCR run, the raw data (Ct-values) were exported to Microsoft Excel 2003. For our 
following calculations we used the Ct-values for each well/ gene. These values give the number of 
PCR cycles that are necessary for the fluorescent signal to exceed the background level. The 
threshold was set manually to 0.3 for all runs. Generally, it has to be placed above the background 
signal and within the lower third to lower half of the linear phase (in the logarithmic view) of the 
amplification plot.
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Genes that are highly expressed, such as housekeeping genes or genes that are upregulated due to 
chemokine stimulation, have low corresponding Ct-values (for housekeeping genes approx. between 
17 and 22) as a high copy number of their mRNA is available, which leads to a quicker increase of the 
fluorescent signal beyond the threshold level.
To be able to compare gene expression between our CXCL2 treated samples and the untreated 
control, we had to do some calculations???????????t –values were calculated for each gene of both runs 
(control run and CXCL2 stimulated run).
??t = CtGene of Interest – CtAverage Housekeeping Genes
???????????????????t were determined for each gene across the two runs.
???t?????tCXCL2 –???tControl
To obtain the fold-change for each of these genes the following equation had to be calculated.
X-fold change = 2^(-???t)
Fold-changes greater than 1 are upregulations, fold-changes lower than 1 down-regulations. This 
means that an X-fold value of 2.5 indicates a 2.5-fold higher gene expression in living cells in 
response to CXCL2 stimulation compared to the untreated situation.
Our PCR-Arrays did not only contain 84 different genes, but also 5 different housekeeping genes (KG) 
and 7 controls (C). The latter served as internal controls for reverse transcription (RTC) and to check 
for rat genomic DNA contamination (RGDC) and any impurities that could affect the PCR reaction 
(PPC). For both plates that we did (control and CXCL2 treatment), all these values were calculated 
and assessed. The control values determined from both PCR arrays were in accordance with the 
standard control values given by the manufacturer.
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2.8. Tissue Sampling & Immunohistochemistry
2.8.1. Material
• Needle, BD Microlance 3, 20G, 0.9 x 40mm (BD)
• 10ml syringe (BD)
• 4% PFA in 0.1M PBS (pH 7.4)
• 1X PBS
• Preparation instruments (tweezers, scissors, …)
• Embedding boxes & paper
• Material for paraffin embedding (done by technicians)
• Material for HE staining (done by technicians)
• Material for Immunohistochemistry (done by technicians)
2.8.2. Method
Animals (0-day, 7-day, 14-day, 21-day, and 28-day old wild-type Lewis and PLP-transgenic Lewis rats) 
were sacrificed by inhalation of an overdose CO2. Afterwards, they were transcardially perfused with 
4% PFA. Brains and spinal cords were dissected and tissue was fixed in 4% PFA for 24 hours at 4°C. 
Brain and spinal cords of newborns and 7-day old pups were incubated for 72 hours in 4% PFA, as the 
tissue was too fragile for tissue preparation after 24 hours. After completed fixation, the tissue was 
washed and stored in 1X PBS at 4°C until tissue section preparation. This was done by cutting brain 
and spinal cord with a razor blade into equal slices. The tissue pieces were stored in 1xPBS (4°C) until 
they were embedded in paraffin.
Paraffin embedding and all subsequent stainings were done by our technicians on the basis of well-
proven standard protocols that will not be included in detail in this diploma thesis.
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Chapter 3
3. Results
This chapter provides the results that were collected during 
diploma thesis work. Since my diploma thesis consisted of three 
different subprojects, results will be presented in three different 
sections.
Based on the classification shown below, results will be presented:
• Characterization of the Postnatal Brain Development of Wild-type and Hemizygous PLP-
Transgenic Lewis Rats
The CNS of wild-type and PLP-transgenic rats were characterized by immunohistochemistry, 
Four different CNS regions were analyzed: cerebral cortex, cerebellum, brain stem, and spinal 
cord. Development of these structures was examined at five different time points: 0, 7, 14, 21, 
and 28 days after birth.
• Analysis of the Global Chemokine Expression Patterns at Different Time Points of Postnatal
Brain Development
We examined chemokine expression patterns of the different CNS structures derived from 
wild-type and PLP-transgenic Lewis rats from postnatal day 0 to postnatal day 28.
• Establishment of Rat Brain Endothelial Cell Cultures and Testing of Their Response to
Chemokines Produced During Postnatal CNS Development
Pure rat brain endothelial cells were established and characterized. A new project concerning 
chemokine stimulation of rat brain endothelial cells was initiated. 
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3.1. Characterization of the Postnatal Brain Development of Wild-
type and Hemizygous PLP-Transgenic Lewis Rats
Since we characterized the postnatal chemokine profile of wild-type and PLP-transgenic rats, it was 
important to get an overview about the histological changes of the target structures studied in the 
course of postnatal development.
Starting with the cerebral cortex, this tissue was characterized by HE stainings to visualize the gross 
tissue architecture. The birth of neurons, their proliferation, differentiation, and migration are events 
which occur prenatally. Also the basic laminar architecture of the cerebral cortex is established 
before birth. After birth, differentiation and remodeling of the cerebral cortex continue. Synapses are 
formed and dendrites and axons grow (Lee et al., 2009). Moreover, cells of the oligodendrocyte 
lineage are born, migrate to their final destination, and start to myelinate axons. Therefore, also 
immunohistochemical stainings of CNPase, as a marker for oligodendrocytes and myelination 
processes, were done. We observed that the different neuronal layers of the cerebral cortex were
already visible at birth. Over the next weeks of postnatal development, the cerebral cortex became
thicker. CNPase+ oligodendrocytes and myelin were not seen at birth. On day 7, the first 
oligodendrocytes were found at the innermost layers of the cortex, next to the corpus callosum. At 
later time points, oligodendrocytes and myelinated internodes were also seen in layers more distant 
to this side (see Figure 13). On the whole, there were no gross differences visible in the level of 
myelination in wild-type animals compared to PLP-transgenic ones, although myelination seems to 
be a little bit faster in transgenic rats than in their wild-type counterparts. Moreover, due to the 
accumulation of myelin proteins in the endoplasmatic reticulum (Bauer et al., 2002), the transgenic 
oligodendrocytes appear swollen and stain darker (compare Figure 13 and Figure 14; see Figure 21).
Already at birth, the cerebellum started to show its characteristic transverse folding. Both, shallow 
and deep transverse folds were observable. Over time, the molecular and granular layers of the 
cerebellar cortex thickened. Wild-type and PLP-transgenic animals displayed essentially the same 
morphological and histological changes during postnatal development. In wild-type and PLP-
transgenic cerebella, CNPase+ oligodendrocytes were already found at birth and located to deep 
cerebellar white matter. The numbers of these cells increased at postnatal day 7. At postnatal day 14 
and later, myelination of the entire deep white matter was visible. Wild-type and PLP-transgenic rats 
essentially showed the same speed of myelination (see Figure 15 and Figure 16).
Generally, cerebral cortex and cerebellum differ from brain stem and spinal cord, as grey matter and 
white matter are arranged the other way round. The grey matter, containing neuronal cell bodies, 
constitutes the outer layer of cerebral cortex and cerebellum, whereas the white matter, containing 
neuronal axons and oligodendrocytes, is buried more deeply in the tissue. Brain stem and spinal cord 
are structured differently with all cell bodies (grey matter) positioned deeply within the tissue and 
their axons and the oligodendrocytes at the outermost layers. 
The medulla oblongata belongs to the brain stem. It represents the lowest part of the brain stem and 
cannot clearly be separated from the spinal cord. Please note that samples for chemokine expression 
microarrays (see Chapter 3.2) that are named “brain stem” also always contain tissue from medulla 
oblongata. 
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Due to technical difficulties, we were not able to cut the medulla oblongata at the same site at 
different stages in development (see Figure 17 and Figure 18). Brain stem pictures of newborn PLP-
transgenic rats are not available as we experienced some problems with tissue sampling of very 
young material. Nevertheless, we obtained important information about the formation of myelin 
sheaths in this part of the brain: Already at postnatal day 0, some CNPase+ oligodendrocytes were 
observable. On P7, myelination was most advanced in the medial longitudinal fasciculus. After P14, 
myelination of the medulla oblongata was essentially complete. There were no substantial
differences between wild-type and PLP-transgenic rats found.
At birth, the spinal cord was functionally and structurally complete and could be clearly divided into 
grey matter (containing neuronal cell bodies) and white matter (containing axons). Myelination in the 
spinal cord essentially started in the white matter. Already at postnatal day 0, a few CNPase+
oligodendrocytes could also be seen in the grey matter. The peak of myelin formation occured at 
postnatal day 14. At this time point, myelin sheaths in the grey matter were also much more 
numerous. At postnatal day 21, myelination of white and grey matter was complete. Due to tissue 
sampling problems, only longitudinal sections were available for newborns, whereas for older 
animals cross sections are shown (see Figure 19 and Figure 20). There is an artifact present in the 
longitudinal section of a wild-type spinal-cord (see Figure 19/ P0/ CNPase), showing PNS nerve fibers 
that heavily stained for CNPase. The longitudinal section of a corresponding PLP-transgenic newborn 
(see Figure 20/ P0/ CNPase) did not contain any parts of PNS and therefore did not show such a 
pronounced CNPase staining.
Within the following pages, results of stained cerebral cortices, cerebella, medulla oblongata, and 
spinal cord sections derived from newborn, 7-, 14-, 21- and 28-day old wild-type and PLP-transgenic 
animals are shown. Due to space restrictions, figure legends are not shown beneath the 
corresponding figures but will be presented afterwards.
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Figure 13: HE and CNPase stainings of cerebral cortex sections derived from wild-type rats (see legend on page 40)
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Figure 14: HE and CNPase stainings of cerebral cortex sections derived from PLP-transgenic rats (see legend on page 40)
Results
34
HE CNPase
P0
P7
P1
4
P2
1
P2
8
Figure 15: HE and CNPase stainings of cerebella sections derived from wild-type rats (see legend on page 40)
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Figure 16: HE and CNPase stainings of cerbella sections derived from PLP-transgenic rats (see legend on page 40)
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Figure 17: HE and CNPase stainings of medulla oblongata sections derived from wild-type rats (see legend on page 40)
Results
37
HE CNPase
P0 Data not available
P7
P1
4
P2
1
P2
8
Figure 18: HE and CNPase stainings of medulla oblongata sections derived from PLP-tg rats (see legend on page 40)
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Figure 19: HE and CNPase stainings of spinal cord sections derived from wild-type rats (see legend on page 40)
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Figure 20: HE and CNPase stainings of spinal cord sections derived from PLP-transgenic rats (see legend on page 40)
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Legend of Figure 13: HE and CNPase stainings of cerebral cortex sections derived from wild-type Lewis rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of cerebral cortex 
sections derived from newborn, 7-, 14-, 21- and 28- day old wild-type Lewis rats. CNPase signals are shown in brown. Cell 
nuclei are stained blue. 4X magnification
Legend of Figure 14: HE and CNPase stainings of cerebral cortex sections derived from PLP-transgenic Lewis rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of cerebral cortex 
sections derived from newborn, 7-, 14-, 21- and 28- day old PLP-transgenic Lewis rats. CNPase signals are shown in brown. 
Cell nuclei are stained blue. 4X magnification
Legend of Figure 15: HE and CNPase stainings of cerebella sections derived from wild-type Lewis rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of cerebellum sections 
derived from newborn, 7-, 14-, 21- and 28- day old wild-type Lewis rats. CNPase signals are shown in brown. Cell nuclei are 
stained blue. 4X magnification
Legend of Figure 16: HE and CNPase stainings of cerebella sections derived from PLP-transgenic Lewis rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of cerebellum sections 
derived from newborn, 7-, 14-, 21- and 28- day old PLP-transgenic rats. CNPase signals are shown in brown. Cell nuclei are 
stained blue. 4X magnification
Legend of Figure 17: HE and CNPase stainings of medulla oblongata sections derived from wild-type rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of medulla oblongata 
sections derived from newborn, 7-, 14-, 21- and 28- day old wild-type Lewis rats. CNPase signals are shown in brown. Cell 
nuclei are stained blue. 4X magnification
Legend of Figure 18: HE and CNPase stainings of medulla oblongata sections derived from PLP-transgenic Lewis rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of medulla oblongata 
sections derived from 7-, 14-, 21- and 28- day old PLP-transgenic Lewis rats. Results for postnatal day 0 are not available. 
CNPase signals are shown in brown. Cell nuclei are stained blue. 4X magnification
Legend of Figure 19: HE and CNPase stainings of spinal cord sections derived from wild-type Lewis rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of spinal cord sections 
derived from newborn, 7-, 14-, 21- and 28- day old wild-type Lewis rats. Artifacts of PNS nerve fibers are present in 
postnatal day 0 tissue. CNPase signals are shown in brown. Cell nuclei are stained blue. 4X magnification
Legend of Figure 20: HE and CNPase stainings of spinal cord sections derived from PLP-transgenic Lewis rats
Shown here are HE stainings (left panel) and immunohistochemical CNPase stainings (right panel) of spinal cord sections 
derived from newborn, 7-, 14-, 21- and 28- day old PLP-transgenic Lewis rats. CNPase signals are shown in brown. Cell 
nuclei are stained blue. 4X magnification
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Overexpression of PLP in hemizygous PLP-transgenic rats results in oligodendrocyte ER stress and to 
an accumulation of myelin proteins in this organelle (Gow et al., 1994) (Casaccia-Bonnefil, 2000)
(Bauer et al., 2002). Therefore, PLP-transgenic oligodendrocytes give a much stronger signal upon 
staining with CNPase than their wild-type counterparts (see Figure 21).
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Figure 21: Oligodendrocyte staining. Shown here are immunohistochemical CNPase stainings spinal cord 
sections derived from 28-day old wild-type and PLP-transgenic rats. CNPase signals are shown in brown. 
Cell nuclei are stained blue. 20X magnification
Since PLP-transgenic oligodendrocytes suffer from ER stress reactions (Gow et al., 1994) (Casaccia-
Bonnefil, 2000) and even become apoptotic, they are often phagocytosed by microglia cells. 
Generally, microglia cells can be classified according to developmental and morphological states into 
different types: amoeboid, intermediate, ramified, primed, and reactive microglia.
Amoeboid microglia cells show a macrophage-like phenotype as they have large cell bodies with 
short processes (see Figure 22). They are abundant in the maturing brain (Ling et al., 1980) (Perry et 
al., 1985). Microglia of this morphological stage phagocytose debris resulting from degradation of 
excess cells in the late embryonic and postnatal phases (Hume et al., 1983) (Ferrer et al., 1990).
During maturation, microglia switch to a ramified appearance and remain so within adult CNS tissue 
(see Figure 22) (Perry and Gordon, 1988). Processes of ramified microglia do not interconnect. This 
morphological state is termed the "resting" state. However, it should be mentioned that “resting” 
microglia cells are not “at rest”, but are engaged in immune surveillance of the CNS (Rivest, 2006).
Upon activation, microglia cells upregulate specific surface markers and respond to pathologic, 
inflammatory, and traumatic stimuli (Streit et al., 1988). Microglia cells, which phagocytose stressed 
oligodendrocytes, assume an amoeboid, macrophage-like phenotype (see Figure 24). Not 
surprisingly, we found many more oligodendrocyte phagocytosing microglia cells in PLP-transgenic 
compared to wild-type tissue.
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Figure 22: Different stages of microglia maturation. Microglia cells that infiltrate the CNS parenchyma 
have an amoeboid, macrophage-like appearance. Mature microglia have a ramified phenotype with lots 
of protrusions that do not interconnect with each other. Modified picture taken from Rezaie and Male 
(1999).
Developmental differences in microglia amounts and distribution in the CNS are remarkable. The 
differences between newborn cortical tissue and 28-day cortical tissue were quite obvious. After 
birth there were hardly any microglia cells present in the cortex, whereas after 28 days the tissue was
numerously populated by microglia (see Figure 23). 
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Figure 23: Microglia staining (Overview). Shown here are immunohistochemical Iba-1 stainings of cerebral 
cortex sections derived from newborn and 28-day old wild-type and PLP-transgenic rats. Given here is an 
overview of microglia amounts and distribution in the cortical tissue. Iba-1 signals are shown in brown. 
Cell nuclei are stained blue. 4X magnification
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Higher magnifications of microglia stainings clearly demonstrated the phenotypic differences 
between immature and mature microglia cells. In 7-day old tissues amoeboid cells were abundant. In 
older animals, ramified microglia cells were present. Due to PLP overexpression and oligodendrocyte 
ER stress, phagocytotically active microglia were found within transgenic tissues (see P28/PLP-
transgenic).
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Figure 24: Iba1 staining (detailed). Shown here are immunohistochemical Iba-1 stainings of cerebral 
cortex sections derived from newborn and 28-day old wild-type and PLP-transgenic rats. Given here is a 
detailed look on the different microglial morphological stages. Iba-1 signals are shown in brown. Cell 
nuclei are stained blue. 4X magnification
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3.2. Analysis of the Global Chemokine Expression Patterns at 
Different Time Points of Postnatal Brain Development
It has been described that chemokine expression patterns within the CNS change in the course of 
time (Schoderboeck et al., 2009). Differences in chemokine production were already observed by
Schoderboeck et al. when spinal cord homogenates were examined. Within this chapter, results are
presented that address differences in chemokine expression patterns of several CNS regions 
(cerebral cortex, cerebellum, brain stem, and spinal cord) of wild-type and PLP-transgenic Lewis rats, 
studied at different time points of postnatal development. For this purpose, pathway-focused 
chemokine microarrays were used (Oligo GE Array® Rat Chemokines & Receptors Microarray, ORN-
022 (SABiosciencesTM)) (see Chapter 2.3).
Throughout this part of results, only data for chemokines, whose presence was found in at least one 
sample, is shown. Chemokines that are not covered in this section were either not expressed at all, 
were expressed at levels below the limit of detection of our method, or were not covered by the 
microarray platform used in our studies. Generally, expression levels of the following chemokines 
were examined: XCL1, CXCL1, CXCL2, CXCL4, CXCL10, CXCL11, CXCL12, CCL2, CCL3, CCL4, CCL5, CCL6, 
CCL7, CCL11, CCL12, CCL17, CCL19, CCL20, CCL21b, CCL22, CCL24, CCL25, CCL27, CCL28, and CX3CL1.
Within this chapter, results are shown in the following order: First, chemokine expression patterns of
the four different examined CNS regions (cerebral cortex, cerebellum, brain stem, and spinal cord) 
will be presented. Thereafter, the same results will be shown according to time points (P0, P7, P14, 
P21, and P28) and genotype (WT = wild-type Lewis; TG = PLP-transgenic Lewis).
As described in the material and methods sections, we normalized the images of the microarrays to 
the expression of the housekeeping genes Ppia and Rpl32.
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In wild-type cerebral cortices, CCL27, CX3CL1, and Endothelial-monocyte activating polypeptide-2
(Emap2) transcripts were constitutively and strongly expressed at all postnatal time points studied. 
RNA levels of CCL7 and CCL24 were highest at postnatal day 0 and declined thereafter. Compared to 
the gene expression levels of CCL7 and CCL24, the amount of transcripts for CCL19, CXCL2, and CXCL4 
were lower, but revealed essentially the same kinetics, with highest expression in P0 animals and a 
marked decrease at later time points. The only other molecules with noticeable gene expression 
were CCL5, CXCL10, and CXCL12, which showed low mRNA expressions at postnatal day 0 that were 
absent at later time points (see Figure 25).
In PLP-transgenic cerebral cortices, CCL27, CX3CL1, and Emap2 were again constitutively expressed, 
although CX3CL1 RNA amounts at postnatal day 0 were lower than at all other time points observed. 
RNA levels of CCL7 and CCL24 were present in P0 animals and highest at postnatal day 7. Also RNA 
transcripts of CCL19, CXCL2, CXCL4, and CXCL10 were more abundant in 7-day old PLP-transgenic 
rats, which is a remarkable difference to wild-type animals. Another molecule with noticeable gene 
expression was IL-18, which was hardly detectable in P0 cortices, showed its peak mRNA expression 
at postnatal day 7 and 14, and was below the limit of detection in P21 and P28 cortices (see Figure 
25).
Figure 25: Chemokine expression in cerebral cortices of wild-type (WT) and PLP-transgenic (TG) Lewis rats 
derived from 0-, 7-, 14-, 21-, and 28-day old animals. The RNA tested was pooled from equal tissue pieces 
of 3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as 
"housekeeping genes" for calibration of the arrays. The following chemokines were also contained on the 
arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, 
CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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In wild-type cerebella, CCL27 and Emap2 transcripts were constitutively and strongly expressed at all 
postnatal time points studied. RNA levels of CX3CL1 were highest in P0 animals, declined at postnatal 
days 7 and 14, again increased in P21, and were completely absent at postnatal day 28. CCL2, CCL7, 
CCL24, and CXCL2 transcript expression was visible at postnatal day 0 and 7 and absent thereafter. 
Transcripts for CCL5, CCL6, CCL19, CXCL4, and IL-18 were found only in P0 animals. Remarkably, the 
signal for CXCL4 expression was quite strong. Compared to the gene expression patterns of the latter 
chemokines mentioned, CCL3 was strongly abundant only at postnatal day 7. Due to some 
difficulties, there are two results missing (P28, WT) (see Figure 26).
In PLP-transgenic cerebella, CCL27 and Emap2 were constitutively expressed. CX3CL1 RNA amounts 
were highest at P0 and P7, still present at P21, and absent at postnatal day 28. RNA levels of the 
chemokines CCL3, CCL7, CCL24, CXCL2, and CXCl4 and the cytokine IL-18 were visible at postnatal day 
0 and 7 and absent thereafter. Remarkably, the signal for CCL24 expression was much stronger in 
PLP-transgenic rats compared to wild-types. Transcripts for CCL2, CCL5, CCL6, CCL19, and CXCL12 
were found only in P7 animals (see Figure 26).
Figure 26: Chemokine expression in cerebella of wild-type (WT) and PLP-transgenic (TG) Lewis rats derived 
from 0-, 7-, 14-, 21-, and 28-day old animals. The RNA tested was pooled from equal tissue pieces of 3-6 
animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as "housekeeping 
genes" for calibration of the arrays. The following chemokines were also contained on the arrays, but did 
not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, CXCL11, CCL4, 
CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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In wild-type brain stems, CCL27, CX3CL1, and Emap2 transcripts were constitutively expressed at all 
postnatal time points studied. Levels of CX3CL1 expression decreased after time point P7. RNA levels 
of CCL7, CCL24, and CXCL4 were highest at postnatal day 0 and 7, and were absent thereafter. The 
only other molecules with noticeable gene expression were CCL6 and IL18, which showed low mRNA 
expression levels only at postnatal day 0. Data for 28-day old rats is not available (see Figure 27).
In PLP-transgenic brain stems, CCL27, CX3CL1, and Emap2 were constitutively expressed as well. 
CX3CL1 RNA amounts were lower at postnatal day 14. RNA levels of CCL7, CCL24 and CXCL4 were 
observed in newborn and 7-day old animals. RNA transcripts of IL-18 were found at postnatal day 7, 
14, and 21. Generally, many more chemokine transcripts were found within 21-day old PLP-
transgenic rats. This includes the expression of CCL3, CCL6, and CCL19 that were completely absent in 
all other transgenic animals, and the expression of CCL7, CCL24, CXCL2, and CXCL4 that were already 
absent in 14-day old rats (see Figure 27). 
Figure 27: Chemokine expression in brain stems (medulla oblongata) of wild-type (WT) and PLP-transgenic 
(TG) Lewis rats derived from 0-, 7-, 14-, 21-, and 28-day old animals. The RNA tested was pooled from 
equal tissue pieces of 3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 
(Rpl32) served as "housekeeping genes" for calibration of the arrays. The following chemokines were also 
contained on the arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, 
CXCL1, CXCL4, CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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In wild-type spinal cords, CCL27 and Emap2 transcripts were constitutively and strongly expressed at 
all postnatal time points studied. CX3CL1 was transcribed in lower amounts, which further decreased 
during development. CCL6, CXCL4, and CXCL10 transcript expression levels were observed at 
postnatal day 0 and 7 and absent thereafter. CCL7 and CCL24 RNA expression were found in spinal 
cords derived from newborn, 7- and 14-day old Lewis rats. Transcripts for CCL5, CXCL12, and IL-18 
were found only in P7 animals. Data for 28-day old rats are not available (see Figure 28).
In PLP-transgenic spinal cords, CCL27 and Emap2 were constitutively expressed. CX3CL1 RNA 
amounts were highest at P0 and P7 and much lower at postnatal day 14, 21, and 28. RNA levels of
the chemokines CCL6, CCL7, CCL19, CXCL2, CXCL4, and CXCL10 and the cytokine IL-18 were visible at 
postnatal day 0 and 7 and absent thereafter. CCL3 expression was observed in spinal cords derived 
from 7-, 21-, and 28-day old PLP-transgenic rats. CCL24 transcript expression was found in every
tissue except for 14-day old rats (see Figure 28).
Figure 28: Chemokine expression in spinal cords of wild-type (WT) and PLP-transgenic (TG) Lewis rats 
derived from 0-, 7-, 14-, 21-, and 28-day old animals. The RNA tested was pooled from equal tissue pieces 
of 3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as 
"housekeeping genes" for calibration of the arrays. The following chemokines were also contained on the 
arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, 
CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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At postnatal day 0, all CNS structures of wild-type rats showed a constitutive expression of CCL27, 
CX3CL1, and Emap2 transcripts. Additionally, cerebral cortex samples showed high expression of 
CCL24 and a moderate expression of CCL7, CXCL2, and CXCL4. Low amounts of CCL3, CCL5, CCL6, 
CCL19, CXCL10, and CXCL12 were also present. Within cerebellar tissue, CCL7, CXCL4 and IL-18 were
abundant, whereas expression levels of CCL2, CCL5, CCL6, CCL19, CCL24, and CXCL2 were much 
lower. Within brain stem and spinal cord tissues, the following chemokines were observable: CCL6, 
CCL7, CCL24, CXCL4, and IL-18 (brain stem only) (see Figure 29).
Also all CNS structures derived from newborn PLP-transgenic rats showed a constitutive expression 
of CCL27, CX3CL1, and Emap2 RNA. Additional transcripts for CCL3, CCL5, CCL6, CCL7, CCL24, CXCL2, 
CXCL4, CXCL10, and IL18 were observed within cortical tissue. Transgenic cerebella and brain stems 
express CCL7, CCL24, CXCL2, and CXCL4 as well as CXCL10 and Il-18 in lower amounts. Within spinal 
cord tissue, abundant transcripts of CCL6, CCL7, CCL24, and CXCL4 were present. Additionally, weak 
signals for CCL19, CXCL2, CXCL10, and IL-18 could be detected (see Figure 29).
Figure 29: Chemokine expression in cerebral cortices, cerebella, brain stems, and spinal cords of newborn 
wild-type (WT) and PLP-transgenic (TG) Lewis rats. The RNA tested was pooled from equal tissue pieces of 
3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as 
"housekeeping genes" for calibration of the arrays. The following chemokines were also contained on the 
arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, 
CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
Results
50
At postnatal day 7, all CNS structures of wild-type rats showed again a constitutive expression of 
CCL27, CX3CL1, and Emap2 transcripts, apart from the CX3CL1 expression level within cerebellar 
tissue. Additionally, cerebral cortex and cerebellum tissues showed expression of CCL3, CCL7, CCL24, 
and CXCL2. Within brain stem and spinal cord samples, CCL7, CCL24, and CXCL4 RNA were detected. 
Additionally, transcripts of CXCL2, CXCL10, CXCL12 and IL-18 were found within brain stems derived 
from 7-day old Lewis rats (see Figure 30).
Also all CNS structures derived from 7-day old PLP-transgenic rats showed a constitutive expression 
of CCL27, CX3CL1, and Emap2 RNA. Additional transcripts for CCL3, CCL6, CCL7, CCL19, CCL24, CXCL2, 
CXCL4, CXCL10, CXCL12, and IL18 were observed within cortical tissue. Basically, cerebellar tissue 
expressed the same chemokines but partly in higher amounts. Transgenic brain stems express CCL7, 
CCL24, CXCL2, CXCL4, and IL-18 in low levels. Within spinal cord tissue, abundant production of 
CXCL4 RNA was detected, as well as lower amounts of CCL3, CCL6, CCL7, CCL24, CXCL2, CXCL10, and 
IL-18 (see Figure 30).
Figure 30: Chemokine expression in cerebral cortices, cerebella, brain stems, and spinal cords of 7-day old 
wild-type (WT) and PLP-transgenic (TG) Lewis rats. The RNA tested was pooled from equal tissue pieces of 
3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as 
"housekeeping genes" for calibration of the arrays. The following chemokines were also contained on the 
arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, 
CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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At postnatal day 14, all CNS structures of wild-type rats showed a constitutive expression of CCL27 
and Emap2 transcripts. Additionally, CX3CL1 expression was found in all parts, although it strongly 
differed. Cerebral cortex samples as well as cerebella, brain stems and spinal cords showed a minor 
expression of CCL7 and CCL24. Spinal cords also expressed transcripts of CXCL4, CXCL10, and IL-18
(see Figure 31). 
All CNS structures derived from 14-day old PLP-transgenic rats showed a constitutive expression of 
CCL27 and Emap2 RNA. Expression levels of CX3CL1 varied between the four observed CNS regions. 
In cerebral cortices, RNA transcripts of CCL7, CCL19, and IL-18 were present. All other tissues did not 
express any additional chemokine transcripts apart from the constitutively expressed ones (see 
Figure 31).
Figure 31: Chemokine expression in cerebral cortices, cerebella, brain stems, and spinal cords of 14-day 
old wild-type (WT) and PLP-transgenic (PLP) Lewis rats. The RNA tested was pooled from equal tissue 
pieces of 3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as 
"housekeeping genes" for calibration of the arrays. The following chemokines were also contained on the 
arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, 
CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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At postnatal day 21, all CNS structures of wild-type rats showed constitutive expression of CCL27 and 
Emap2 transcripts. Expression of CX3CL1 varied and was highest in cerebral cortex tissue. 
Additionally, transcripts for CCL7, CCL24, and CXCL2 were found. The same expression patterns were 
observed in cerebellar samples. Brain stem and spinal cord samples did not show any chemokine
expression patterns, apart from the constitutively expressed ones (Figure 32). 
All CNS structures derived from 21-day old PLP-transgenic rats showed a constitutive expression of 
CCL27and Emap2 RNA. We also observed strong signals for CX3CL1 transcription, except for 
cerebellar samples. The cerebral cortex did not express any additional chemokines whereas 
transcripts for CCL7 and CCL24 were found in cerebellar tissue. An even more varying expression 
pattern was found to be expressed within brain stems derived from 21-day old PLP-transgenic rats: 
CCL3, CCL6, CCL7, CCL19, CCL24, CXCL2, CXCL4, and IL-18 were transcribed, additionally to the 
constitutively expressed chemokines CCL27, CX3CL1, and Emap2. Fewer signals were observed within 
spinal cord samples, which expressed only CCL3 and CCL24 (Figure 32).
Figure 32: Chemokine expression in cerebral cortices, cerebella, brain stems, and spinal cords of 21-day 
old wild-type (WT) and PLP-transgenic (TG) Lewis rats. The RNA tested was pooled from equal tissue 
pieces of 3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as 
"housekeeping genes" for calibration of the arrays. The following chemokines were also contained on the 
arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, 
CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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For postnatal day 28, some data are not available: These include brain stem and spinal cord tissues as 
well as two specific genes (Rpl32 and Emap2) of cerebellar tissue. Results that were available at the 
latest time point we examined showed constitutive expression of CCL27, CX3CL1, and Emap2 within 
the cerebral cortex as well as an additional RNA expression of the chemokines CCL7, CCL24, and 
CXCL2. Apart from the expression of housekeeping genes and CCL27, no additional transcripts were 
found in cerebellar samples (see Figure 33).
All CNS structures derived from 28-day old PLP-transgenic rats showed a constitutive expression of 
CCL27, CX3CL1, and Emap2 RNA. Only in cerebellar samples, no CX3CL1 transcripts were found. 
Within cerebral cortices, cerebella and brain stems, no additional chemokine signals were observed, 
apart from the constitutively expressed ones. Only spinal cords, derived from 28-day old PLP-
transgenic rats, showed increased expression levels of CCL3 and CCL24 (see Figure 33).
Figure 33: Chemokine expression in cerebral cortices, cerebella, brain stems, and spinal cords of 28-day 
old wild-type (WT) and PLP-transgenic (TG) Lewis rats. The RNA tested was pooled from equal tissue 
pieces of 3-6 animals. Peptidylprolyl isomerase A (PPia) and the ribosomal protein L32 (Rpl32) served as 
"housekeeping genes" for calibration of the arrays. The following chemokines were also contained on the 
arrays, but did not yield hybridization signals with the calibration conditions used: XCL1, CXCL1, CXCL4, 
CXCL11, CCL4, CCL11, CCL12, CCL17, CCL20, CCL21b, CCL22, CCL25, and CCL28.
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3.3. Establishment of Rat Brain Endothelial Cell Cultures and Testing 
of Their Response to Chemokines Produced During Postnatal 
CNS Development
3.3.1. Establishment of Primary Cultures
Within the last project, rat brain endothelial cell cultures were established that could be used to 
study the interactions of chemokines with endothelial cells in vitro. Therefore, pure rat brain 
endothelial cell cultures without contaminating astrocytes and pericytes were needed. According to 
Perrière et al. we treated our freshly isolated endothelial cells with 4µg or 3µg puromycin for 2 or 3
days, respectively, to get rid of any interfering cell populations (Perrière et al., 2005). Endothelial 
cells highly express P-glycoprotein (P-gp), a multi drug resistance protein that forms a transporter 
(PGP-pump), which actively, upon ATP-consumption, pumps out toxic substances (Nicolazzo and 
Katneni, 2009). Astrocytes and pericytes cells do not express this efflux pump and are therefore not 
capable of surviving puromycin treatment. 
Freshly isolated endothelial cells adhered to collagen-coated surfaces over night (see Figure 34).
Figure 34: Rat brain endothelial cells 1 day after isolation. Attached endothelial cells that already started 
proliferating are flat and appear dark, whereas cells that did not yet adhere or start proliferation are 
round and appear bright when examined through phase contrast. 10X magnification
Already one day after isolation, small colonies could be detected that grew to confluent cell 
monolayers within the following 5-8 days (see Figure 35). Within the first three days, endothelial cells
grew into small star-shaped colonies (compare 1 day with 3 days pictures in Figure 35). The cells 
themselves changed their phenotype from round to spindle-shaped during proliferation. Endothelial 
cells preferred to be seeded in high concentrations and grew badly if splitted into too many dishes 
after isolation. For our stimulation studies, we usually isolated cells from ten 7-to 10-week old rats to 
obtain two confluent 35mm dishes after 5 days (including 2-day 4µg puromycin treatment). For 
microscopy, cells were seeded in lower concentrations as confluency was not necessary. Therefore, 
cells in Figure 35 are not confluent after 5 days, as microscopy samples were pictured.
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Figure 35: Endothelial cell proliferation in the course of time. This overview depicts the different stages in 
colony formation of freshly isolated rat brain endothelial cells. Pictures were taken 1, 3, 4, and 7 days 
after isolation. Pictures were taken with a phase contrast microscope. 10X magnification
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Without puromycin treatment, extensive growth of contaminating cells was observed. Based on their 
shape, we assume that this cell population mostly consisted of pericytes and astrocytes. The
contaminants were removed upon addition of puromycin (see Figure 36). Also at late time points, 
interfering cells did not reappear and we were able to obtain pure rat brain endothelial cell cultures
with insignificant amounts of astrocytes and pericytes.
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Figure 36: Growth of contaminating cells is abolished after puromycin treatment. Shown in the left panel 
are untreated endothelial cells after 4 and 6 days in culture. The right panel shows cells that were treated 
with puromycin and grown for 4 and 6 days, either. Pictures were taken from areas between endothelial 
cell colonies to prove the absence of any contaminants. 
3.3.2. Characterization of the Endothelial Cell Cultures
After establishment of pure endothelial cell cultures by puromycin treatment, we had to prove that 
the addition of this antibiotic did not alter the cells’ properties. Four different markers were chosen
to compare untreated and puromycin treated cell cultures:
• Von Willebrand factor (vWF), Factor VIII related antigen
• ZO-1, zona occludens-1
• Ox7, CD90, Thy1.1
• Ox26, CD71, transferrin receptor
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Von Willebrand factor (vWF), a multimeric glycoprotein, can be found in blood plasma, blood 
platelets, and endothelial cells as it binds to blood clotting factor VIII and is involved in the adhesion 
of blood platelets to endothelial tissue (Sadler, 1998). VWF is solely expressed in endothelial cells 
(Jaffe et al., 1974) and megakaryocytes (Nachman et al., 1977). Intracellularly, vWF is localized in so-
called Weibel-Palade bodies (Sadler, 1998), which results in a very granular staining pattern.
Zona occludens-1 (ZO-1) is a multidomain scaffold protein that tethers tight junction proteins such as 
occludin to the cells’ actin cytoskeleton (Fanning et al., 1998). It is exclusively concentrated at 
endothelial tight junctions. For us, it serves as a marker to prove that the behavior of our puromycin 
treated cells mimic the in vivo situation, meaning that the endothelial cells were still able to form 
tight junctions even after puromycin treatment in vitro.
The surface protein Thy1 (other names: Ox7, CD90) is known to be expressed on many cell types, 
including thymocytes, neuronal cells, stem cells, immature B cells, and connective tissue cells 
(Campbell et al., 1981). It also serves as a marker for pericytes (Dai et al., 2009) and is therefore used 
to determine endothelial cell culture purity. Pure cultures should not stain for Thy1. 
The transferrin receptor (other names: Ox26, CD71) is expressed on the surface of several cell types 
that require iron. This includes brain endothelial cells (Jefferies et al., 2010).
We found that untreated and puromycin-treated rat brain endothelial cells express vWF (see Figure 
37), ZO1 (see Figure 38), and the transferrin receptor (see Figure 39). As expected, Ox7+ pericytes 
were only seen in cultures grown in the absence of puromycin (see Figure 38)
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Figure 37: Staining pattern of von Willebrand factor. Untreated and puromycin-treated rat brain 
endothelial cells were reacted with rabbit-?-vWF (1:100), biotinylated donkey-?-rabbit (1:1000), and 
streptavidin-Cy3 (1:100) antibodies. VWF positive endothelial cells appear red. Nuclei were 
counterstained with DAPI (blue).
Legend of Figure 38: 
Untreated and puromycin-treated rat brain endothelial cells were reacted with mouse-?-Thy1 (1:250), donkey-?-mouse-
Cy2 (1:200), rabbit-?-ZO1 (1:50), and goat-?-rabbit-Cy3 (1:100) antibodies. Thy1 positive pericytes appear green, ZO1 
positive endothelial cells appear red. Nuclei were counterstained with DAPI (blue).
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Figure 38: Staining patterns of Thy1 and ZO1.
(see detailed legend on previous page)
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Figure 39: Staining pattern of transferrin receptor. Untreated and puromycin-treated rat brain endothelial 
cells were reacted with mouse-?-Ox26 (1:100), biotinylated donkey-?-mouse (1:250), and streptavidin-
Cy3 (1:100) antibodies. Ox26 positive endothelial cells appear red. Nuclei were counterstained with DAPI 
(blue).
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Figure 40: Negative control. Rat brain endothelial cells were reacted with donkey-?-mouse-Cy2 (1:200) 
and goat-?-rabbit-Cy3 (1:100) antibodies. Nuclei were counterstained with DAPI (blue). Secondary 
antibodies did not unspecifically bind to the endothelial cells.
In summary, puromycin treatment of rat brain endothelial cells did not alter the cells’ characteristics. 
They still expressed endothelial cell markers such as von Willebrand factor, ZO-1 and transferrin 
receptor. Puromycin treated cell cultures did not stain for Thy1, the marker for contaminating cells. 
Hence, our puromycin treated rat brain endothelial cell cultures were pure and could therefore be 
used for further experiments.
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3.4. Chemokine Stimulation of Rat Brain Endothelial Cells
During our microarray studies, we found low expression of CXCL2 in several different structures of 
the CNS, particularly on postnatal day 7 (see Figure 30). This was particularly interesting since 
injection of CXCL2 into the striatum of juvenile (3-week old) rats leads to neutrophil-mediated break-
down of the blood-brain barrier (Anthony et al., 1998), a feature that could be reproduced in our 
laboratory as well (see Figure 41).
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Figure 41: Neutrophil recruitment into the striatum after injection of PBS or CXCL2. Erythrocytes in the 
lesions indicate the position of the needle tract. Only few neutrophils (black arrows) with their typical 
lobular nuclei (shown in detail in the insert) are found in close vicinity to the injection site after PBS 
injection but were much more numerous and migrated deeper into the tissue after injection of CXCL2.
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Interestingly, CXCL2 induces much stronger responses in young animals compared to adult ones 
(Anthony et al., 1998). Still, there are many unsolved questions concerning this topic: How do CXCL2 
(and also CXCL1) exactly exert their functions? Are there amplification cascades or do endothelial 
cells lose their barrier functions only because of chemokine binding? Which other molecules are 
upregulated due to chemokine stimulation? Why is there such a strong neutrophil response?
We decided to address these questions using pathway-focused PCR-Arrays (RT2 ProfilerTM PCR Array, 
Rat Endothelial Cell Biology, PARN-015C (SABiosciencesTM)). These real-time PCR Arrays assess the 
amount of transcribed mRNA of 84 different genes that are known to exert functions in endothelial 
cell biology (see Table 6; wells A1 to G12).
We started our stimulation experiments with treating rat brain endothelial cells with 10ng/µl CXCL2 
for 6 hours. To be able to compare mRNA levels of treated samples to untreated ones, a control 
sample had to be done as well. Further treatments (other chemokines, other time points) will not be 
shown in this diploma thesis and are part of further investigations in the future.
Treatment of rat brain endothelial cells with CXCL2 did not lead to overt morphological changes in 
cultured endothelial cells (see Figure 42). 
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Figure 42: Comparison of untreated and 6-hour CXCL2 treated rat brain endothelial cells
After treatment, cells were lysed and RNA was isolated (see Chapter 2.2). Thereafter, cDNA was 
transcribed and the PCR-Arrays were run (see Chapter 2.7).
As we used the SybrGreen technique, we had to check the melting curve of each well for quality 
control after every run. A perfect dissociation curve is a steep single-peak that reaches its maximum 
value at 80°C or more. Wells that did not contain such a well-defined curve were marked (see Table
6; * tagged wells) and will be treated with caution during data analysis as primer dimers may have
occurred that could result in false positive values. Pictures containing all 96 melting curves for each 
sample are shown in Figure 43. This figure also gives the amplification plots in a logarithmic view. 
Genes that are highly expressed (such as housekeeping genes) have low Ct-values (x-axis “Cycle”) and 
therefore their related curves are the ones that are located on the more left side.
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Figure 43: Amplification Plots and Melting Curves of untreated control sample and CXCL2 stimulated 
sample
Compared to their untreated counterparts, CXCL2 treated endothelial cells revealed a strong 
upregulation of several genes (see Table 6). Values that are highlighted grey correspond to genes 
that showed at least 2-fold increases in gene expression. Interestingly, there was no downregulation 
of gene transcripts that was higher than 2-fold (= values below 0.5). 
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Well No. Name X-fold ñò Well No. Name X-fold ñò
A1 Ace 3.115 E1 Mmp9 0.885
A2 Adam17 1.891 E2 Nos2 1.181
A3 Agt 11.392 E3 Nos3 1.728
A4 Agtr1b 1.577 E4* Nppb 0.891
A5 Angpt1 10.395 E5 Npr1 1.341
A6 Anxa5 0.801 E6 Pdgfra 2.970
A7 Bax 1.345 E7 Pecam 1.307
A8 Bcl2 1.738 E8 Cxcl4 1.008
A9 Bcl2l1 1.448 E9 Pgf 0.642
A10* Birc1b 1.454 E10 Plat 1.887
A11 Blr1 2.346 E11 Plau 1.898
A12 Casp1 1.568 E12* Plg 4.645
B1 Casp3 1.143 F1 Ptgis 2.447
B2 Casp6 1.239 F2 Ippk 1.879
B3 Ccl2 1.430 F3 Rhob 1.848
B4 Ccl5 0.954 F4 Sele 1.955
B5 Cdh5_predicted 1.104 F5 Sell 1.697
B6 Cflar 1.034 F6 Selp 2.187
B7 Col18a1 1.955 F7 Serpine1 0.928
B8 Cpb2 2.174 F8 Sod1 0.854
B9 Cradd 1.256 F9 Tek 1.897
B10 Csf2 4.964 F10 Tfpi 1.439
B11 Cx3cl1 0.637 F11 Tgfb1 0.915
B12 Cxcl1 2.667 F12 Thbd 2.279
C1 Cxcl2 2.563 G1 Thbs1 0.924
C2 Ecgf1 1.137 G2 Timp1 1.347
C3 Edn1 1.245 G3 Tnf 0.616
C4* Edn2 2.973 G4 Tnfrsf6 1.615
C5* Ednra 2.144 G5 Tnfsf10 2.539
C6* Fgf1 1.451 G6 Faslg 2.021
C7 Fgf2 2.127 G7 Tnip2 1,232
C8 Flt1 1.016 G8 Ocln 0.983
C9 Fn1 1.563 G9 Vcam1 2.378
C10 Icam1 1.179 G10 Vegfa 2.032
C11* Ifnb1 2.692 G11 Vwf 2.161
C12 Il11 1.006 G12 Xdh 2.221
D1* Il1b 2.987 H1 HK Rplp1 1.095
D2* Il3 0.802 H2 HK Hprt 0.998
D3 Il6 1.071 H3 HK Rpl13a 0.864
D4 Il7 0.615 H4 HK Ldha 1.034
D5 Itga5 1.679 H5 HK Actb 1.024
D6 Itgav_predicted 1.106 H6 C RGDC - - -
D7 Itgb1 1.157 H7 C RTC - - -
D8 Itgb3 0.952 H8 C RTC - - -
D9 Kdr 1,543 H9 C RTC - - -
D10 Kit 1.670 H10 C PPC - - -
D11 Mmp1a_predicted 17.943 H11 C PPC - - -
D12 Mmp2 1.243 H12 C PPC - - -
Table 6: Up- (>1) and down- (<1) regulation of certain genes. Given are all X-fold values of the 84 genes 
involved in endothelial cell biology and of the five housekeeping genes (HK) contained on the PCR array. 
Also shown are the internal controls (C). Values highlighted grey show at least 2-fold increases in gene 
expression. Wells with abnormal melting curves are tagged with an asterisk.
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Many of the differentially expressed genes belong to functional groups involved in blood vessel 
formation, blood pressure regulation, anticoagulation, breakdown of the extracellular matrix, 
neutrophil activation, and B-cell migration (see Table 7). The upregulation of gene transcripts 
involved in neutrophil activation and adhesion was particularly interesting for us, because it could 
provide the basis for the neutrophil-mediated blood brain barrier break-down in the immature rat 
CNS already observed in the study of Anthony et al. (1998).
Gene Description X-fold ñ
Blood vessel formation
(Thurston, 2003)
Angpt1 Angiopoietin 1 10.395
Vegfa Vascular endothelial growth factor A (VEGF-A) 2.032
Blood pressure regulation & functional maintenance of the BBB
(Riordan, 2003) (Kakinuma et al., 1998) (Reid et al., 1978)
Ace Angiotensin I converting enzyme (ACE) 3.115
Agt Angiotensinogen 11.392
Blood vessel constriction & blood pressure raise
(Barnes and Turner, 1997)
Edn2* Endothelin 2 2.973
Ednra* Endothelin receptor type A 2.144
Vasodilation & anticoagulation
(Dewitt et al., 1983) (Esmon, 1995)
Plg Plasminogen 4.645
Ptgis Prostaglandin I2 synthase 2.447
Thbd Thrombomodulin 2.279
Plat Plasminogen activator, tissue-type 1.887
Plau Plasminogen activator, urokinase-type 1.898
Breakdown of extracellular matrix
(Nagase and Woessner, 1999)
Mmp1a Matrix metallopeptidase 1a (interstitial collagenase) 17.943
Neutrophil activation & adhesion
(Gomez-Cambronero, 2003) (Anthony et al., 1998) (Lomakina and Waugh, 2009)
Csf2 Colony stimulating factor 2 (GM-CSF) 4.964
Cxcl1 CXCL1 2.667
Cxcl2 CXCL2 2.563
Selp p-Selectin 2.187
Vcam1 Vascular cell adhesion molecule 1 2.378
B-Cell migration
(Förster et al., 1996)
Blr1 Burkitt lymphoma receptor 1 (CXCR5) 2.346
Table 7: Overview of selected genes. Shown here are important genes that were upregulated in CXCL2 
stimulated cells (6 hours) compared to unstimulated cells. 
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Chapter 4
4. Discussion
This final chapter discusses the results in relation to published 
literature. The subprojects " Characterization of the Postnatal 
Brain Development of Wild-type and Hemizygous PLP-
Transgenic Lewis Rats" and "Analysis of the Global Chemokine 
Expression Patterns at Different Time Points of Postnatal Brain 
Development" are discussed together as they closely refer to 
each other. Subsequently, the "Establishment of Rat Brain 
Endothelial Cell Cultures and Testing of Their Response to 
Chemokines Produced During Postnatal CNS Development" is
discussed. Additionally a short outlook on future work is
provided. 
There is evidence that immature animals and humans are much more susceptible to brain 
inflammation than older ones. Children, compared to adults, are at higher risk to experience 
persisting brain damage and death after head injury or infection (Anthony et al., 1998) (Sharples et 
al., 1995) (Rosenfeld and Rowley, 1994) (Tuomanen, 1994). Animal studies showed that younger 
animals tend to develop acute, severely damaging responses more easily than adult ones (Anthony et 
al., 1998) (Galea et al., 2007) (Umehara et al., 1990).
This “window of susceptibility” in young individuals might be partly determined by the expression of 
certain chemokines that have dual roles in development and inflammation. Therefore, a different 
chemokine pattern within the immature CNS compared to the adult one is necessary, but might also 
account for the enhanced susceptibility towards inflammatory and damaging stimuli. Chemokines, 
secreted by CNS cells, diffuse through the CNS parenchyma (Fuentes et al., 1995) and are transported 
to the luminal side of endothelial cells by vesicular-mediated transcellular processes (Middleton et 
al., 1997) (Dar et al., 2005) (Mordelet et al., 2007) (Ge et al., 2008). Chemokines probably bind to 
proteoglycan-like molecules on the surface of endothelial cells (Rot, 1992) (Tanaka et al., 1993), 
which leads to a retention of chemokines in the blood vessels. The presence of a leaky blood-brain 
barrier in immature rats could contribute to the exit of chemokines from the CNS parenchyma and 
their availability on blood vessel surfaces, which could lead to the attraction of inflammatory cells 
and subsequent CNS damage. Interestingly, blood vessels of young rats express more dysferlin, a 
marker for leaky blood vessels. (Hochmeister et al., 2006) (Schoderboeck et al., 2009). In muscle 
cells, dysferlin is important for the fusion of repair vesicles with the plasma membrane (Bansal and 
Campbell, 2004) (Liu et al., 1998). The coincidence of the presence of dysferlin+ vessels and the 
involvement of dysferlin in vesicular transport processes could explain some mechanisms in the 
context of the "window of susceptibility".
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Leaky blood vessels and a different chemokine expression pattern in immature brains compared to 
adult ones would explain the high susceptibility of young individuals towards pathologic brain 
conditions. Therefore, it is important to know exactly which chemokines are basically expressed 
during postnatal brain development. We assessed the chemokine expression patterns of the cerebral 
cortex, the cerebellum, the medulla oblongata, and the spinal cord of newborn, 7-, 14-, 21-, and 28-
day old wild-type and PLP-transgenic Lewis rats. This basic research revealed pronounced differences 
in CNS chemokine expression patterns between relatively young pups (newborns and 7-day old rats) 
and older ones (14- to 28-day old rats). The remarkable reduction of chemokine production within 
the first weeks of life is consistent with literature indicating that major transcriptional changes occur
between P0 and P14 (Lee et al., 2009). Differences were not only observed on molecular levels but 
also in histochemical stainings of corresponding brain sections. Within the first week of life, the 
different CNS parts are structurally complete and myelination, which was mostly absent at P0, was 
initiated.
Generally, the development of the CNS can be divided into the prenatal and postnatal periods. Birth, 
proliferation, differentiation, and also the major part of neuronal migration within the cerebral 
cortex are finished within the prenatal phase. Postnatally, further differentiation and remodeling of 
the cortex take place although without any changes to the basic laminar architecture (Lee et al., 
2009). This is confirmed by our HE stainings of sections derived from the cerebral cortex, the 
cerebellum, the brain stem, and the spinal cord.
Developmental loss of transcript expression applies to the following chemokines examined: CCL2, 
CCL3, CCL5, CCL6, CCL7, CCL19, CXCL2, CXCL4, CXCL10, and CXCL12. Selected chemokines will be 
discussed further:
Signals for CCL2 are completely absent after P7. This chemokine participates in promotion of 
neuritogenesis (Edman et al., 2008) and astrocyte differentiation (Lawrence et al., 2006). The
observed loss of CCL2 perfectly matches the development of the postnatal CNS which obviously does 
not need any more CCL2 after establishment and refining of basic CNS structures.
The chemokine CCL3 influences migration of oligodendrocyte lineage cells whereas their proliferation 
is not affected (Nguyen et al., 2003). Already in 2003, Cowell and Silverstein suggested that the 
expression of CCL3 is developmentally regulated as the corresponding receptor CCR1 is present on 
neurons and astrocytes in 7-day old rat forebrains but absent from adult brain tissue (Cowell and 
Silverstein, 2003). CCL3 participates in the appropriate migration of oligodendrocyte precursor cells, 
required for correct myelination of neurons, by negatively influencing migratory processes (Nguyen 
et al., 2003). Nguyen et al. suggest a possible role of CCL3 in oligodendrocyte regeneration and axon 
remyelination. Their proposal would be in agreement with our observations of increased CCL3 levels 
within PLP-transgenic tissues. 
Transcript expression of CCL6, which is capable of inducing microglia and astrocyte migration (Kanno 
et al., 2005) was absent after postnatal day 7, whereas expression levels of CCL7, which regulates 
neuritogenesis (Edman et al., 2008), persist in all cortical samples which we examined (until P28). 
The chemokine CXCL4 exhibits antiangiogenic properties. It inhibits the proliferation and migration of 
endothelial cells and angiogenesis in vitro as well as in vivo (Bikfalvi and Gimenez-Gallego, 2004). 
CXCL4 expression levels are pronounced in P0 and P7 tissues and abruptly absent in P14 samples. 
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Termination of brain development seems to be associated with the termination of extensive 
angiogenesis which takes place during colonization of brain tissue. 
CXCL12 and its receptor CXCR4 definitely exhibit developmental functions as CXCL12- and CXCR4-
deficient mice show abnormal development of cerebellum and hippocampus (Ma et al., 1998) (Zhu 
et al., 2002) (Lu et al., 2002). CXCL12 is involved in the migration of neural cells (Ni et al., 2004) and 
modulates oligodendrocyte precursor cells (Dziembowska et al., 2005) (Maysami et al., 2006). Its 
expression later than time point P7 is not observed in our studies. Interestingly, expression levels 
within 7-day old tissue are higher than in tissue derived from newborns.
As shown, many chemokines are not expressed within mature brains and only few are still present.
Within CNS parenchyma, CX3CR1, the receptor of the chemokine CX3CL1, is solely expressed in 
microglia (Cardona et al., 2006). Soluble CX3CL1 exhibits neurotrophic effects, suggesting that it is 
involved in cellular communications between neurons and glial cells (Meucci et al., 2000). CX3CL1 
expression levels are decreased in 14-, 21-, and 28-day old cerebella, brain stem, and spinal cord 
tissues compared to the corresponding samples derived from newborn and 7-day old rats. Solely in 
cortices, CX3CL1 levels remain high which suggests an important role of this chemokine in 
maintenance of cortical neuronal networks.
Our data revealed clear age-dependent differences in chemokine expression patterns, showing a high
and wide-ranging chemokine production within immature brain regions. Many of developmental 
processes are controlled by the examined chemokines and therefore their absence after the 
termination of basic brain development (migration, differentiation and maturation of neurons and 
glial cells) is not surprising.
Interestingly, Rostene et al. report about the neuroanatomical localization of CCL2 and its receptor 
CCR2 in adult rat brain. These results give evidence for a constitutive expression of CCL2 and CCR2
(Rostene et al., 2007), localized in glial cells and neuronal cell bodies, which was definitely not found 
in our study and other literature (Schoderboeck et al., 2009). Rostene et al. additionally state a 
neuromodulatory function of CCL2. Also CXCL2 modulates neurotransmitter release. It enhances
post-synaptic currents in patch-clamped Purkinje neurons of rat cerebellar slices (Ragozzino et al., 
1998). The two chemokines CXCL1 and CXCL8, which were not included in our microarray studies, 
appear to have neuromodulatory functions as well namely in cerebellar synaptic activity (Giovannelli 
et al., 1998).
During the period of increased susceptibility, the blood-brain barrier is at great risk of neutrophil-
mediated breakdown (Anthony et al., 1998). For example, injection of interleukin-1? (IL-1?) into the 
brain parenchyma of adult rats results in no notable increase in vascular permeability. Administration 
of an even lower dose of IL-1? into juvenile rat brains leads to a strong increase of blood-brain 
barrier permeability and neutrophil recruitment (Anthony et al., 1997). Besides their bacteria
neutralizing function after infections and their involvement mediating tissue injury, neutrophils are 
also important during the acute phase of infections to prevent spreading of necrosis to healthy brain 
parenchyma, ultimately minimizing tissue damage. Neutrophil-depletion in mice leads to a much 
higher bacterial burden 5 days after injection of Staphylococcus aureus-laden agarose beads into 
their brains compared to untreated mice (Kielian et al., 2001). Kielian et al. additionally characterize
the chemokine production within infected tissue and show an induction of numerous chemokines, 
including CCL1, CCL2, CCL3, CCL4, CXCL1, CXCL2, and CXCL10. CXCL1 and CXCL2 both bind to CXCR2 
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and belong to the ELR+ subfamily of CXC chemokines that mainly act as neutrophil attractants (Laing 
and Secombes, 2004). CXCR2 knockout mice show significant impairment in neutrophil extravasation 
into the brain parenchyma after S. aureus administration. Their neutrophils are not able to respond 
to CXCL1 and CXCL2 any longer although the latter ones are still produced within the infected tissue. 
Bacterial burdens are also higher due to the absence of neutrophils (Kielian et al., 2001).
The next part of our study concentrates on the responses of endothelial cells to chemokines with 
known neutrophil-attracting functions. The comparison of RNA expression levels within endothelial 
cells treated with 10ng/µl CXCL2 (6 hours) to expression levels of unstimulated cells resulted in 
several upregulated genes. Most noticeable, marker for Neutrophil activation and adhesion (GM-CSF, 
CXCL1, CXCL2, p-selectin, Vcam1) were significantly increased. GM-CSF is a very potent neutrophil 
chemoattractant and enhances the function of neutrophils (Gomez-Cambronero, 2003). It shows an 
almost 5-fold increase in expression level after CXCL2 treatment. In vitro studies with human 
neutrophils demonstrate that GM-CSF is able to strongly enhance the cell's directional movements 
when examined in transwell-plates (Gomez-Cambronero et al., 2003). After treatment with CXCL2, 
rat brain endothelial cells also produce CXCL1 and CXCL2 on their own, which probably acts as signal 
enhancement. VCAM1 and p-selectin play important roles in the adhesion of neutrophils and 
generally of leukocytes to activated endothelial cells, and thus promote entry of these cells into the 
CNS in the course of inflammation (Lomakina and Waugh, 2009) (Prendergast and Anderton, 2009).
Under physiological conditions, p-selectin is stored in Weibel-Palade bodies of endothelial cells. Due 
to inflammatory stimuli, p-selectin is transported to the surface of endothelial cells. Its common 
ligand p-selectin glycoprotein ligand 1 (PSGL-1) is expressed on the surfaces of many leukocytes, 
including neutrophils (Chen and Geng, 2006). Earlier reports suggested that the interaction of 
neutrophils with activated endothelium via VLA-4/VCAM-1 interaction is not possible (Yusuf-
Makagiansar et al., 2002). More recent findings disprove this opinion by showing that inflammatory 
stimuli are very well able to significantly upregulate VLA-4 presentation on neutrophils (Reinhardt et 
al., 1997) (Reinhardt and Kubes, 1998).
Intrastriatal injection of 30ng CXCL2 leads to massive recruitment of neutrophils to the site of 
injection and, additionally, to the healthy brain parenchyma. This indicates an impaired blood-brain 
barrier function and provides another evidence of the potent neutrophil-attracting function of 
CXCL2.
Apart from the latter molecules that play roles directly in neutrophil activation and adhesion, and in 
blood-brain barrier impairment, the following proteins are also upregulated in CXCL2-treated 
endothelial cells:
Angiotensin-I-converting enzyme (ACE) catalyzes the cleavage of angiotensin I to angiotensin II and 
therefore participates in a system that regulates blood pressure, blood vessel constriction, and the 
volume and composition of the extracellular fluid (Riordan, 2003). Angiotensinogen is converted to 
angiotensin I by renin and constitutes the starting point of the whole “renin-angiotensin system” 
(Reid et al., 1978). Additionally, angiotensinogen-deficient mice have impaired blood-brain barrier 
functions as their astrocytes lack normal angiotensinogen expression and are no longer capable of 
restoring BBB maintenance after brain injuries (Kakinuma et al., 1998). Therefore, this system is 
known to primarily control blood pressure, but is also essential for BBB function and repair. This 
assumption is strengthened by the fact that stimulation of rat brain endothelial cells with CXCL2 
resulted in 3- and 11-fold higher levels of ACE and angiotensinogen, respectively.
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The almost 18-fold increase of matrix metallopeptidase 1a (MMP1a; collagenase) transcription 
confirmed our suspicion that CXCL2 treated rat brain endothelial cells digest collagen. Our initial 
finding was based on the decreased 260/230nm absorbance ratio of isolated mRNA. This low ratio 
indicated high carbohydrate content within the sample which we thought resulted from increased 
collagenase activity of the cells leading to the break-down of the dishes’ collagen-coating that had 
been enriched with carbohydrates by the endothelial cells before. This suspicion seems to be
confirmed by the findings of an upregulated MMP1a, although one has to be careful with 
interpretations, as the findings might not represent in vivo conditions. Our dishes are coated with 
collagen type I, which is found in the interstitial matrix that is usually not part of the extracellular 
matrix (ECM) of the BBB. The ECM mainly comprises collagen type IV that is degraded by MMP2 and 
MMP9 (Zeng et al., 1999), which both are gelatinases. MMP2 and MMP9 expression levels were both 
examined but their levels are not significantly increased, which is not surprising as no collagen type 
IV was available. 
The observed upregulations of endothelin 2 and endothelin receptor type A have to be considered 
with special caution. For both proteins, abnormal melting curves were detected, which tells us that 
an early fluorescent signal is not necessarily due to high gene expression but can be also be assigned 
to primer dimers. Generally, endothelins act as vasoconstrictors, neuropeptides, and morphogens 
(Barnes and Turner, 1997). However, as long as the increase of both substances is not proven by 
other methods (ELISA, Immunohistochemistry), we will not dare to state special functions for 
endothelin 2 and endothelin receptor type A in CXCL2 treated endothelial cells.
Interestingly, CXCR5 (also called Burkitt lymphoma receptor 1) expression levels are also elevated in 
CXCL2 treated rat brain endothelial cells. CXCL13, the B-cell attracting chemokine, is the only one 
known to bind to CXCR5. Both, the receptor and VCAM1, are involved in B-cell migration (Förster et 
al., 1996).
Angiopoietin and vascular endothelial growth factor A (VEGF-A) participate in the formation of blood 
vessels although they have been found to play complementary roles. The VEGF system seems to be 
involved in vessel sprouting and new vessel formation whereas angiopoietins are said to play roles in 
remodelling, maturation, and stabilization (Thurston, 2003). CXCL2 stimulation induces a strongly 
increased angiopoietin 1 expression (10-fold upregulation) which indicates the involvement of 
endothelial cells in the restructuring and stabilization of blood vessels during lymphocyte 
extravasation. Upregulation of VEGF-A (2-fold) supports the initiation of new vessels.
Plasminogen, prostaglandin I2 synthase, and thrombomodulin, proteins that are involved in 
vasodilation and anticoagulation (Esmon, 1995) (Dewitt et al., 1983), were significantly increased 
upon CXCL2 treatment. Interestingly, tissue-type plasminogen activator (tPA), an enzyme typically 
found in the blood and contributing to thrombolysis, shows a 1.9-fold upregulation (Yepes et al., 
2003). Apart from its thrombolytic function, tPA is able to induce the opening of the blood-brain 
barrier. Yepes et al. show that after cerebral ischemia, there is an increased tPA activity. Injection of 
tPA into the cerebrospinal fluid also results in a rapidly increased BBB permeability. BBB opening is 
not due to urokinase-type plasminogen activator (also 1.9-fold upregulated) and also plasminogen 
independent (Yepes et al., 2003).
Treatment of rat brain endothelial cells with CXCL2 was only the first of many stimulation studies 
that will be done in the near future. Our chemokines of choice will be CXCL1 with its known 
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neutrophil-attracting function, and some other chemokines identified by our microarray studies. We 
intend to find out, how endothelial cells react to such stimuli and how they contribute to a blood-
brain barrier break down leading to the entry of damaging agents into the CNS parenchyma. 
Additionally, we will also proceed with the intrastriatal chemokine injections to monitor the different 
cell types infiltrating the brain parenchyma and the molecules released. 
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6. Supplementary Data
This chapter shows detailed gene tables and the precise real-
time PCR results. Supplementary data is presented according to 
subprojects.
Supplementary Data of: Analysis of the Global Chemokine Expression Patterns at
Different Time Points of Postnatal Brain Development
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Figure 44: Gene arrangement on Oligo GE Array® Rat Chemokines & Receptors Microarray, ORN-022 (SABiosciencesTM)
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Pos. Symbol Description
1 Ppia Peptidylprolyl isomerase A
2 Agtrl1 Angiotensin receptor-like 1
3 Appils Leucyl-specific aminopeptidase PILS
4 Bdnf Brain derived neurotrophic factor
5 Blr1 Burkitt lymphoma receptor 1
6 Bmp15 Bone morphogenetic protein 15
7 Bmp6 Bone morphogenetic protein 6
8 Bmpr1b Similar to Bone morphogenetic protein binding serine/threonine kinase 
receptor
9 C5 Complement component 5
10 Ccl19 Ccl19
11 Ccl2 Ccl2
12 Ccl22 Ccl22
13 Ccl24 Ccl24
14 Ccl25 Ccl25
15 Ccl3 Ccl3
16 Ccl5 Ccl5
17 Ccl6 Ccl6
18 Ccl7 Ccl7
19 Ccr1 Ccr1
20 Ccr1l1 Ccr1 like 1
21 Ccr2 Ccr2
22 Ccr6 Ccr6
23 Ccr7 Ccr7
24 Ccr8 Ccr8
25 Ccr9 Ccr9
26 Ccrl2 Similar to putative beta chemokine receptor
27 Cklf1 Chemokine-like factor 1
28 Cklfsf2a Similar to chemokine-like factor super family 2A
29 Cklfsf3 Similar to RIKEN cDNA
30 Cklfsf4 Similar to chemokine-like superfamily 4
31 Cklfsf5 Similar to chemokine-like superfamily 5
32 Cklfsf6 Similar to Da2-17
33 Cklfsf7 Similar to LNV
34 Cklfsf8 Chemokine-like factor superfamily 8
35 Cmkbr3 Ccr3
36 Cmkbr4 Ccr4
37 Cmkbr5 Ccr5
38 Cmklr1 Chemokine-like receptor 1
39 Csf1 Colony stimulating factor 1 (macrophage)
40 Csf2 Colony stimulating factor 2 (granulocyte-macrophage)
41 Csf3 Colony stimulating factor 3
42 Cx3cl1 Cx3cl1
43 Cxcl1 Cxcl1
44 Cxcl10 Cxcl10
45 Cxcl11 Cxcl11
46 Cxcl12 Cxcl12
47 Cxcl2 Cxcl2
48 Cxcl4 Cxcl4
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49 Cxcr4 Cxcr4
50 Cyfip2 Similar to p53 inducible protein
51 D6 CC-chemokine-binding receptor JAB61
52 Ecgf1 Similar to thymidine phosphorylase
53 Epo Erythropoietin
54 Gca Similar to Gca protein
55 Gdf6 Growth differentiation factor 6
56 Gpr2 Similar to 7-transmembrane G-protein coupled receptor 2
57 Gpr77 G protein-coupled receptor 77
58 Gpr81 Similar to G protein-coupled receptor 81
59 Gpr9 G protein-coupled receptor 9
60 Hc Similar to Complement C5 precursor
61 Hif1a Hypoxia inducible factor 1, alpha subunit
62 Il13 Interleukin 13
63 Il16 Interleukin 16
64 Il18 Interleukin 18
65 Il1a Interleukin 1 alpha
66 IL-1Rrp Similar to IL-1Rrp
67 Il2 Interleukin 2
68 Il4 Interleukin 4
69 Il8ra Interleukin 8 receptor, alpha
70 Il8rb Interleukin 8 receptor, beta
71 Inha Inhibin alpha
72 Inhbb Inhibin beta-B
73 Lif Leukemia inhibitory factor
74 Ltb4r2 Leukotriene B4 receptor 2
75 Mig Monokine induced by gamma interferon
76 Mmp2 Matrix metalloproteinase 2
77 Mmp7 Matrix metalloproteinase 7
78 Mmp8 Neutrophil collagenase
79 Myd88 Myeloid differentiation primary response gene 88
80 C20orf175 Similar to chromosome 20 orf 175
81 Gpr43 Similar to Gpr43 protein
82 Nfkb1 Nuclear factor kappa B p105 subunit
83 Prl Prolactin
84 Pumag Interferon-gamma inducible gene
85 Rbs11 Rbs11 protein
86 Rdc1 Chemokine orphan receptor 1
87 Rgs3 Regulator of G-protein signaling 3
88 Scya11 Ccl11
89 Scya12 Ccl12
90 Scya17 Ccl17
91 Scya19 Ccl19
92 Scya20 Ccl20
93 Scya21b Ccl21b
94 Scya27 Ccl27
95 Scya28 Ccl28
96 Scya4 Ccl4
97 Scyc1 Xcl1
98 Scye1 Endothelial monocyte activating polypeptide 2
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99 SDF-2 Similar to Stromal cell-derived factor 2 precursor
100 Sdf1l1 Similar to SDF2 like protein 1
101 Sfrp1 Secreted frizzled-related protein 1
102 Slit2 Slit homolog 2
103 Tapbp TAP binding protein
104 Tcp10c Similar to T-complex protein 10c
105 Tlr1 Similar to toll-like receptor 1
106 Tlr2 Toll-like receptor 2 variant 1
107 Tlr3 Toll-like receptor 3
108 Tlr4 Toll-like receptor 4
109 Tlr5 Toll-like receptor 5
110 Tnf Tumor necrosis factor superfamily, member 2
111 Tnfrsf1a Tumor necrosis factor receptor superfamily, member 1a
112 Trem1 Similar to TREM-1
113 Trem2 Similar to triggering receptor TREM-2A
114 Xcr1 Similar to SCM1 receptor mXCR1
115 PUC18 PUC18 Plasmid DNA
116 Luc1 Luciferase probe 1
117 Luc2 Luciferase probe 2
118 AS1R2 Artificial Sequence 1 Related 2
119 AS1R1 Artificial Sequence 1 Related 1
120 AS1 Artificial Sequence 1
121 Rpl32 Ribosomal protein L32
122 Ldha Lactate dehydrogenase A
123 Aldoa Aldolase A
124 Aldoa Aldolase A
125 Gapd Glyceraldehyde-3-phosphate dehydrogenase
126 Gapd Glyceraldehyde-3-phosphate dehydrogenase
127 BAS2C Biotinylated Artificial Sequence 2 Complementary sequence
128 BAS2C Biotinylated Artificial Sequence 2 Complementary sequence
Table 8: Gene table of Oligo GE Array® Rat Chemokines & Receptors Microarray, ORN-022 (SABiosciencesTM)
Supplementary Data
79
Supplementary Data of: Establishment of Rat Brain Endothelial Cell Cultures and
Testing of Their Response to Chemokines Produced During Postnatal CNS
Development
Well Symbol Description
A1 Ace Angiotensin I converting enzyme
A2 Adam17 TNF alpha converting enzyme
A3 Agt Angiotensinogen
A4 Agtr1b Angiotensin receptor 1b
A5 Angpt1 Angiopoietin 1
A6 Anxa5 Annexin A5
A7 Bax Bcl2-associated X protein
A8 Bcl2 B-cell leukemia/lymphoma 2
A9 Bcl2l1 Bcl2-like 1
A10 Birc1b Baculoviral IAP repeat-containing 1b
A11 Blr1 Burkitt lymphoma receptor 1
A12 Casp1 Caspase 1
B1 Casp3 Caspase 3, apoptosis related cysteine protease
B2 Casp6 Caspase 6
B3 Ccl2 CCL2
B4 Ccl5 CCL5
B5 Cdh5 Cadherin 5 (predicted)
B6 Cflar CASP8 and FADD-like apoptosis regulator
B7 Col18a1 Procollagen, type XVIII, alpha 1
B8 Cpb2 Carboxypeptidase B2
B9 Cradd CASP2 and RIPK1 domain containing adaptor with death domain
B10 Csf2 Colony stimulating factor 2
B11 Cx3cl1 CX3CL1
B12 Cxcl1 CXCL1
C1 Cxcl2 CXCL2
C2 Ecgf1 Endothelial cell growth factor 1
C3 Edn1 Endothelin 1
C4 Edn2 Endothelin 2
C5 Ednra Endothelin receptor type A
C6 Fgf1 Fibroblast growth factor 1
C7 Fgf2 Fibroblast growth factor 2
C8 Flt1 FMS-like tyrosine kinase 1
C9 Fn1 Fibronectin 1
C10 Icam1 Intercellular adhesion molecule 1
C11 Ifnb1 Interferon beta 1
C12 Il11 Interleukin 11
D1 Il1b Interleukin beta 1
D2 Il3 Interleukin 3
D3 Il6 Interleukin 6
D4 Il7 Interleukin 7
D5 Itga5 Integrin alpha 5 (mapped)
D6 Itgav Integrin alpha V (predicted)
D7 Itgb1 Integrin beta 1
D8 Itgb3 Integrin beta 3
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D9 Kdr Kinase insert domain protein receptor
D10 Kit V-kit Hardy Zuckerman 4 feline sacroma viral oncogene homolog
D11 Mmp1a Matrix metallopeptidase 1a (interstitial collagenase)
D12 Mmp2 Matrix metallopeptidase 2
E1 Mmp9 Matrix metallopeptidase 9
E2 Nos2 Nitric oxide synthase 2
E3 Nos3 Nitric oxide synthase 3
E4 Nppb Natriuretic peptide precursor type B
E5 Npr1 Natriuretic peptide receptor 1
E6 Pdgfra Platelet derived groth factor receptor alpha
E7 Pecam Platelet/endothelial cell adhesion molecule
E8 Cxcl4 CXCL4
E9 Pgf Placental growth factor
E10 Plat Plasminogen activator, tissue
E11 Plau Plasminogen activator, urokinase
E12 Plg Plasminogen
F1 Ptgis Prostaglandin I2 synthase
F2 Ippk Inositol 1,3,4,5,6-pentakiphosphate 2-kinase
F3 Rhob Ras homolog gene family, member B
F4 Sele Selectin, endothelial cell
F5 Sell Selectin, lymphocyte
F6 Selp Selectin, platelet
F7 Serpine1 Serine (or cysteine) peptidase inhibitor
F8 Sod1 Superoxide dismutase 1
F9 Tek Endothelial-specific receptor tyrosine kinase
F10 Tfpi Tissue factor pathway inhibitor
F11 Tgfb1 Transforming growth factor beta 1
F12 Thbd Thrombomodulin
G1 Thbs1 Thrombospondin 1
G2 Timp1 Tissue inhibitor of metallopeptidase 1
G3 Tnf Tumor necrosis factor
G4 Tnfrsf6 Tumor necrosis factor receptor superfamily
G5 Tnfsf10 Tumor necrosis factor superfamily
G6 Faslg Fas ligand
G7 Tnip2 TNFAIP3 interacting protein 2
G8 Ocln Occludin
G9 Vcam1 Vascular cell adhesion molecule 1
G10 Vegfa Vascular endothelial growth factor A
G11 Vwf Von Willebrand factor
G12 Xdh Xanthine dehydrogenase
H1 Rplp1 Ribosomal protein large, P1
H2 Hprt Hypoxanthine guanine phosphoribosyl transferase
H3 Rpl13a Ribosomal protein L13A
H4 Ldha Lactate dehydrogenase A
H5 Actb Actin beta
H6 RGDC Genomic DNA Contamination
H7 RTC Reverse Transcription Control
H8 RTC Reverse Transcription Control
H9 RTC Reverse Transcription Control
H10 PPC Positive PCR Control
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H11 PPC Positive PCR Control
H12 PPC Positive PCR Control
Table 9: Gene table of RT2 ProfilerTM PCR Array, Rat Endothelial Cell Biology, PARN-015C (SABiosciencesTM)
Control (C) CXCL2 treated (T) ?? 2^(-?????
?? ??? ?? ??? C - T = X-fold ñò
A1 Ace 22,4068 2,8265 21,4806 1,1874 -1,6390 3,115
A2 Adam17 23,1320 3,5517 22,9257 2,6325 -0,9191 1,891
A3 Agt 35,7750 16,1947 32,9779 12,6847 -3,5100 11,392
A4 Agtr1b 36,9229 17,3426 36,9782 16,6851 -0,6575 1,577
A5 Angpt1 33,8724 14,2920 31,2073 10,9142 -3,3779 10,395
A6 Anxa5 21,3582 1,7778 22,3909 2,0978 0,3199 0,801
A7 Bax 22,3194 2,7391 22,6046 2,3115 -0,4276 1,345
A8 Bcl2 27,8775 8,2972 27,7931 7,5000 -0,7972 1,738
A9 Bcl2l1 23,1750 3,5947 23,3539 3,0608 -0,5339 1,448
A10 Birc1b 39,4641 19,8838 39,6369 19,3437 -0,5400 1,454
A11 Blr1 29,2560 9,6756 28,7387 8,4455 -1,2301 2,346
A12 Casp1 24,7997 5,2194 24,8633 4,5701 -0,6493 1,568
B1 Casp3 22,1481 2,5678 22,6683 2,3752 -0,1926 1,143
B2 Casp6 25,2845 5,7041 25,6875 5,3944 -0,3097 1,239
B3 Ccl2 22,3904 2,8100 22,5873 2,2942 -0,5158 1,430
B4 Ccl5 28,3269 8,7465 29,1073 8,8141 0,0676 0,954
B5 Cdh5 20,3213 0,7410 20,8912 0,5981 -0,1429 1,104
B6 Cflar 21,8824 2,3020 22,5465 2,2533 -0,0487 1,034
B7 Col18a1 21,4268 1,8465 21,1723 0,8792 -0,9673 1,955
B8 Cpb2 35,3279 15,7476 34,9206 14,6274 -1,1202 2,174
B9 Cradd 27,3695 7,7892 27,7537 7,4606 -0,3286 1,256
B10 Csf2 30,3100 10,7297 28,7113 8,4181 -2,3116 4,964
B11 Cx3cl1 22,7410 3,1606 24,1048 3,8116 0,6510 0,637
B12 Cxcl1 23,8240 4,2436 23,1215 2,8283 -1,4153 2,667
C1 Cxcl2 26,6001 7,0198 25,9552 5,6621 -1,3577 2,563
C2 Ecgf1 28,0217 8,4414 28,5493 8,2562 -0,1852 1,137
C3 Edn1 18,7779 -0,8024 19,1745 -1,1187 -0,3162 1,245
C4 Edn2 37,3475 17,7671 36,4882 16,1950 -1,5721 2,973
C5 Ednra 29,8986 10,3182 29,5110 9,2179 -1,1003 2,144
C6 Fgf1 31,2095 11,6291 31,3856 11,0924 -0,5367 1,451
C7 Fgf2 33,0082 13,4279 32,6320 12,3389 -1,0890 2,127
C8 Flt1 25,0804 5,5000 25,7697 5,4766 -0,0234 1,016
C9 Fn1 20,5925 1,0122 20,6613 0,3681 -0,6440 1,563
C10 Icam1 22,7659 3,1855 23,2414 2,9482 -0,2373 1,179
C11 Ifnb1 38,6503 19,0700 37,9346 17,6415 -1,4285 2,692
C12 Il11 30,6724 11,0920 31,3770 11,0838 -0,0082 1,006
D1 Il1b 36,5445 16,9642 35,6786 15,3854 -1,5788 2,987
D2 Il3 33,7722 14,1918 34,8029 14,5097 0,3179 0,802
D3 Il6 27,7782 8,1979 28,3922 8,0991 -0,0988 1,071
D4 Il7 31,5000 11,9196 32,9141 12,6209 0,7013 0,615
D5 Itga5 22,8416 3,2613 22,8069 2,5138 -0,7475 1,679
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D6 Itgav 23,4149 3,8346 23,9829 3,6898 -0,1449 1,106
D7 Itgb1 20,5035 0,9232 21,0064 0,7133 -0,2099 1,157
D8 Itgb3 24,3803 4,8000 25,1644 4,8713 0,0713 0,952
D9 Kdr 20,1732 0,5929 20,2606 -0,0326 -0,6254 1,543
D10 Kit 23,8277 4,2473 23,8011 3,5079 -0,7394 1,670
D11 Mmp1a 39,3369 19,7565 35,8844 15,5912 -4,1653 17,943
D12 Mmp2 24,7998 5,2195 25,1985 4,9054 -0,3141 1,243
E1 Mmp9 31,8328 12,2525 32,7220 12,4289 0,1764 0,885
E2 Nos2 29,2555 9,6752 29,7286 9,4355 -0,2397 1,181
E3 Nos3 22,3366 2,7563 22,2600 1,9669 -0,7894 1,728
E4 Nppb 31,2383 11,6580 32,1169 11,8237 0,1658 0,891
E5 Npr1 24,6766 5,0963 24,9657 4,6726 -0,4237 1,341
E6 Pdgfra 35,1374 15,5570 34,2796 13,9864 -1,5706 2,970
E7 Pecam 18,3748 -1,2055 18,7012 -1,5920 -0,3865 1,307
E8 Cxcl4 31,5848 12,0044 32,2857 11,9926 -0,0119 1,008
E9 Pgf 19,5208 -0,0595 20,8719 0,5787 0,6382 0,642
E10 Plat 21,2016 1,6212 20,9986 0,7054 -0,9158 1,887
E11 Plau 26,5920 7,0117 26,3805 6,0874 -0,9243 1,898
E12 Plg 39,6139 20,0336 38,1110 17,8178 -2,2158 4,645
F1 Ptgis 27,5538 7,9734 26,9753 6,6822 -1,2913 2,447
F2 Ippk 26,6902 7,1099 26,4933 6,2002 -0,9097 1,879
F3 Rhob 20,8409 1,2605 20,6673 0,3742 -0,8863 1,848
F4 Sele 23,7872 4,2069 23,5328 3,2397 -0,9672 1,955
F5 Sell 35,2686 15,6882 35,2183 14,9251 -0,7631 1,697
F6 Selp 25,3851 5,8048 24,9687 4,6755 -1,1292 2,187
F7 Serpine1 16,7616 -2,8188 17,5816 -2,7116 0,1072 0,928
F8 Sod1 20,4285 0,8482 21,3698 1,0766 0,2285 0,854
F9 Tek 21,8379 2,2576 21,6274 1,3342 -0,9233 1,897
F10 Tfpi 20,6773 1,0970 20,8654 0,5723 -0,5247 1,439
F11 Tgfb1 21,5610 1,9806 22,4020 2,1088 0,1282 0,915
F12 Thbd 25,9061 6,3258 25,4305 5,1374 -1,1884 2,279
G1 Thbs1 17,8977 -1,6826 18,7242 -1,5690 0,1136 0,924
G2 Timp1 21,6699 2,0896 21,9525 1,6593 -0,4302 1,347
G3 Tnf 33,8891 14,3087 35,3008 15,0077 0,6989 0,616
G4 Tnfrsf6 28,2117 8,6313 28,2328 7,9396 -0,6917 1,615
G5 Tnfsf10 26,2403 6,6599 25,6087 5,3155 -1,3444 2,539
G6 Faslg 32,6035 13,0231 32,3011 12,0079 -1,0152 2,021
G7 Tnip2 26,0126 6,4323 26,4246 6,1315 -0,3008 1,232
G8 Ocln 24,1029 4,5226 24,8411 4,5480 0,0254 0,983
G9 Vcam1 24,9789 5,3986 24,4420 4,1489 -1,2497 2,378
G10 Vegfa 27,1058 7,5254 26,7957 6,5025 -1,0229 2,032
G11 Vwf 22,2672 2,6869 21,8684 1,5752 -1,1117 2,161
G12 Xdh 26,7333 7,1530 26,2946 6,0015 -1,1515 2,221
H1 Rplp1 17,8887 -1,6916 18,4710 -1,8221 -0,1305 1,095
H2 Hprt 23,5737 3,9934 24,2888 3,9956 0,0023 0,998
H3 Rpl13a 18,5349 -1,0454 19,4581 -0,8351 0,2104 0,864
H4 Ldha 20,7531 1,1727 21,4182 1,1251 -0,0476 1,034
H5 Actb 17,1513 -2,4290 17,8297 -2,4635 -0,0345 1,024
H6 RGDC Undetermined 35,7840
H7 RTC 22,8695 22,5441
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H8 RTC 22,7869 22,4660
H9 RTC 22,8163 22,4292
H10 PPC 17,9456 18,1749
H11 PPC 17,7774 17,9972
H12 PPC 17,9098 17,9902
Table 10: Detailed data on Ct, ?Ct, and ??Ct values derived from RT-PCR analysis of CXCL2-treated endothelial cells 
compared with untreated control
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